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T 7 fails to productively infect E. coli cells containing the plasmid F, a
phenomenon now referred to as F exclusion.  The F protein PifA and the T7
proteins gp10 and gp1.2 are known to be responsible for exclusion.  Co-
expression of pifA and gene 1.2 or pifA and gene 10is known to be lethal to E.
coli; selecting for survivors of a lethal challenge pifA and gene 1.2 resulted in the
isolation of a strain containing the fxsAp109 mutation.  This mutation leads to
overproduction of the inner membrane protein FxsA.  The same mutation had
been isolated previously by selecting survivors of pifA and gene 10co-expression,
suggesting that both combinations, PifA plus gp10, and PifA plus gp1.2, attack
vi
the same or similar cellular function.  FxsA is not this function, rather,
overexpression of fxsA serves a protective role.
PifA has been shown to interact with gp10 (Kd=0.3µM) and gp1.2
(Kd=1µM), whereas mutant gp10 and gp1.2, synthesized by mutant phages that
escape F exclusion, bind with dramatically reduced affinity.  FxsA also interacts
with PifA, gp10A and gp1.2. It was shown that gp1.2 and FxsA bind to the of C-
terminal 254 residues of PifA while gp10A interacts with the region between
residues 181 and 463.
PifA fractionates with the cytoplasmic membrane of E. coli but may only
be membrane-associated, whereas FxsA was shown to possess four
transmembrane segments.  Both the N- and C-termini of FxsA are cytoplasmic
but the hydrophilic C-terminus is not required for FxsA function; conversely, the
fourth transmembrane segment of FxsA is essential for function.  As gp10A and
gp1.2 are localized in the cytoplasm, these proteins likely interact with FxsA and
PifA at the cytoplasmic membrane.  This membrane is therefore the site within
E.coli where F exclusion of T7 is initiated.
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1 Chapter 1: Introduction
Extrachromasomal parasites of bacterial cells such as plasmids and
prophages have evolved various mechanisms by which they maintain their territory
and protect their hosts from certain other infecting bacteriophages or colonizing
plasmids. Plasmids and prophages can protect their host in a variety of ways that
include conferring immunity to superinfection by homoimmune phages, altering
specific receptors to block phage adsorption, preventing DNA ejection by adsorbed
phage, and degrading unmodified DNA that does enter the cell. Less well
understood are those phage infections that abort midway through their infection
cycle. During an abortive infection, the individual infected cell dies before
producing progeny phage, thereby allowing the overall survival of a bacterial
population. A common characteristic of abortive infections is that initial events
appear normal, but thereafter a plethora of physiological defects are observed that,
in many cases, lead to a cessation of all macromolecular synthesis and other
processes in the cell. The severity of phage exclusion is often affected by both the
genetic background and the physiological state of the restrictive host cell. These
observations suggest that either expression of the exclusion functions or their
interactions with cellular components vary during cell growth. Abortive infections
thus provide model systems for studies of the interactions between a host and its
parasite.
2A large number of phage exclusion systems are known and some have been
extensively studied. Examples include exclusion of T4 rII mutants by l  lysogens,
exclusion of T7 by the F plasmid, exclusion of T5 and BF 23 by the Col lb
plasmid, and exclusion of T4 by E. coli lit (Con) strains. Because extensive
knowledge on the genetics, biochemistry and biology of T7 has been accumulated,
the abortive infection of T7 provides a convenient system to study the interactions
between a host and its parasites. The physiological defects associated with each
system overlap substantially and there may be a common mechanism of exclusion.
Therefore, it is likely that an elucidation of one system will help us to understand
the others.
Productive infections by bacteriophage T7
A T7 phage particle consists of an icosahedral capsid (icosahedral
symmetry, T=7) with a short, non-contractile tail (Fig. 1). The phage capsid
contains 415 molecules of gp10A or gp10B (Steven and Truss, 1986). At one
vertex of the icosahedron, 12 molecules of gp8 serve as the head-tail connector for
the phage tail; the latter is comprised of 6 copies of gp12 and 12 copies of gp11.
Gp6.7 is also likely part of the tail but its precise location and stoichiometry have
not been determined. Six tail fibers, each composed of trimers of gp17, are
attached to the tail just below its junction with the head-tail connector protein.
Three major internal proteins, gp14 (18 copies), gp15 (12 copies) and gp16 (3
3Figure 1.  Bacteriophage T7 particle
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5copies), constitute a hollow cylindrical core structure that is attached to the inner
surface of the capsid and the head-tail connector (Steven and Truss, 1986;
1986; Serwer, 1976). This internal core is essential for both phage morphogenesis
and DNA ejection (Cerritelli et al., 1997). Other head proteins include gp7.3, and
perhaps both gp13 and gp7, but their functions are not well-described.
The T7 genome is a linear-double-stranded DNA molecule of 39,937 base-
pairs that is terminally redundant but not circularly permuted (Ritchie et al., 1967).
Originally, 19 genes were defined genetically, these were assigned with integral
numbers sequentially from left to right of the genome beginning at gene 1 (Studier,
1969). As additional genes were discovered they were given fractional numbers in
accordance with their positions (Fig. 2). Now, 56 genes are predicted although
only 39 gene products have been detected (Dunn and Studier, 1983). Less than half
of the genes are essential for phage growth on laboratory strains.
Three classes of genes have been identified. Ten class I, or early, genes are
clustered to the left-most 19% of the genome and are transcribed by E. coli RNA
polymerase. They encode functions that include inhibition of the host type I
restriction system, inactivation of host transcription, conversion of host
metabolism to the production of T7 phage and a new RNA polymerase. Class II
genes, located between 15% and 46% of the genome, and class III genes, located
in the right half of the genome, are both transcribed by T7 RNA polymerase. Class
6II genes primarily function in T7 DNA metabolism whereas class III genes are
involved in phage morphogenesis and maturation or in cell lysis.
Adsorption of T7 to E. coli is initiated by the attachment of its tail fibers to
the lipopolysaccharide of the host cell outer membrane. Following adsorption, a
signal is transduced into the phage head resulting in the ejection of gp6.7 and
gp7.3 into the outer membrane. The internal core structure then disaggregates and
its components (gp14, gp15 and gp16) also enter the cell through the connector
and tail. Gp14 becomes localized in the outer membrane; gp15 and gp16 span the
periplasm and the cytoplasmic membrane, and together the three proteins form a
transmembrane channel for DNA translocation. The N-terminal region of gp16 is
homologous to the soluble lytic transglycosylase of E. coli and may enlarge a hole
through the peptidoglycan layer. This activity of gp16 is important only when cells
are at high density or low temperature, conditions likely favoring increased cross-
linking of peptidoglycan (Moak and Molineux, 2000).
Once the transmembrane channel has formed, the phage genome can leave
the capsid. About 850 bp at the left end of the genome, containing the E. coli
promoters designated A1, A2 and A3, are brought into the cell by a transcription-
independent mechanism (Moffatt and Studier, 1988; Garcia and Molineux, 1995).
Translocation of the leading end of the genome into the host cell is thought to be
driven by an enzymatic motor, likely consisting of gp16 and gp15, and to be
powered by the proton motive force. After entry of ~850 bp, this motor stops. E.
7 coli RNA polymerase then transcribes the class I genes (Minkley and Pribnow,
1973; Dunn and Studier, 1983) and in doing so pulls the first 19 % of the genome
into the cell (Garcia and Molineux, 1995). Most early transcription terminates at
the rho-independent early terminator TE, located between gene 1.3 and 1.4 (Dunn
and Studier, 1980). TE is not wholly efficient, and readthrough transcripts
terminate, also inefficiently, near the 3’ end of gene 3.5, distal to 10 at the T7 RNA
polymerase terminator, or at the end of the genome.
There are five RNase III recognition sites in the class I polycistronic
mRNA. These early transcripts are cleaved to form shorter messages, most of
which are still polycistronic (Dunn and Studier, 1973; Robertson et al., 1977). The
processed transcripts are then heavily translated. Between 2 and 4 min after
infection, the class I gene products gp0.3, gp0.7 and gp1 become detectable
(Studier, 1972). During this period, gp0.3 binds to and inactivates host type I
restriction enzymes (Studier, 1975; Mark and Studier, 1981; Bandyopadhyay et al.,
1985); gp0.7, a serine/threonine-specific, cAMP-independent protein kinase, shuts
down all host transcription and thus indirectly directs the translation machinery to
phage mRNAs (Rothman-Denes et al., 1973). The latter become abundant as gp1,
T7 RNA polymerase, begins to transcribe class II and class III genes (Chamberlin
et al., 1970; Summers and Siegel, 1970). As the synthesis of class II gene products
begins, gp0.7 shuts off class I gene transcription (Rothman-Denes et al., 1973;
Rahmsdorf et al., 1974; Hesselbach and Nakada, 1977).
8Synthesis of class II mRNA is initiated from ten class II promoters (Dunn
and Studier, 1983). The majority of transcripts from these promoters terminate at
Tø, located just downstream of gene 10. T7 RNA polymerase reads through Tø
about 20% of the time and readthrough transcripts stop near the genome end (Niles
and Condit, 1975; McAllister and McCarron, 1977; McDonald et al., 1994). Class
II mRNAs are also processed by E. coli RNase III. Between 4 and 6 min post-
infection, class II proteins are first detected (Studier, 1972). The majority of class
II proteins are involved in phage DNA metabolism. Gp3 (endonuclease) and gp6
(exonuclease) digest the host genome into nucleotides that are then used for phage
DNA synthesis (Center et al., 1970; Sadowski and Kerr, 1970; Kerr and Sadowski,
1972). Gp2.5 (single-stranded DNA-binding protein), gp4A (helicase + primase
activity), 4B (helicase activity) and gp5 (DNA polymerase) are directly involved in
synthesizing T7 DNA. 15 minutes after infection, class II protein synthesis is
normally shut-off by an unknown mechanism.
Class III proteins are synthesized from 6 and 8 minutes post-infection until
cell lysis, which occurs 25-30 min post-infection at 30° C. During this period, while
class III genes are being heavily transcribed and their mRNAs are rapidly
translated, class II transcription is selectively turned off. T7 lysozyme (gp3.5)
binds to T7 RNA polymerase and prevents its isomerization from the initiation to
elongation complex (Zhang and Studier, 1997). Although the class III promoters
are more efficient at initiating transcription than the class II promoters on linear
9templates, the inhibition by T7 lysozyme shows no promoter preference in vitro
(Ikeda, 1992; Ikeda and Bailey, 1992). Class II promoters produce less mRNA,
mainly because of an increased frequency of abortive initiation, which is further
enhanced by formation of a complex of T7 RNA polymerase and lysozyme (Zhang
and Studier, 1997; Lyakhov et al., 1998). Abortive initiation is the main reason
why class II promoters appear weaker than class III promoters, and why class II
gene expression is selectively shut-off during infection.
T7 DNA synthesis starts about 10 min post-infection and, by measurements
of thymidine incorporation, stops at cell lysis (Studier, 1972). However, most of
the increase in T7 DNA occurs between about 15 to 20 minutes. The ø1.1A and
ø1.1B T7 promoters, located 15% from the left end of the genome, serve as origins
of replication (Tamanoi et al., 1980; Saito et al., 1980). T7 RNA polymerase
initiates DNA replication by synthesizing primers of 10-60 nucleotides from both
promoters. T7 DNA polymerase (gp5 + thioredoxin) then displaces T7 RNA
polymerase from DNA, and a gp4A and gp4B complex assembles to form a
hexameric donut shape structure on the single-stranded DNA at the opened
replication origin (Engelman et al., 1995). Gp4 then translocates 5’ to 3’ to unwind
unreplicated DNA using ribo- or deoxy-NTP hydrolysis for energy (Hingorani et
al., 1997). The helicase interacts with both gp2.5 (single-stranded DNA-binding
protein) and DNA polymerase to make DNA synthesis more processive.
Replication proceeds bi-directionally on the linear genome (Fuller and Richardson,
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1985), and synthesis on the leading and lagging DNA strands is tightly coupled by
the gp4 complex (Lee et al., 1998).
The replicated DNA molecules connect to each other in a left end to right
end fashion via the terminal repeat to form linear concatemers. As replication
proceeds, linear concatemers are converted into highly branched DNA through
homologous recombination. Recombination requires gp2.5, gp4, gp3 and gp6, but
is independent of the host recombination system (Powling and Kinppers, 1974;
Kerr and Sadowski, 1975; Kong and Richardson, 1996). Eventually, the complex
of concatemers containing more than 100 genome equivalents is converted by gp3
(Holliday junction resolvase) into linear concatemers that are substrates for the
packaging machinery (De Massy et al., 1987; Kong and Richardson, 1996; Kong
et al., 1997).
As DNA replication progresses, the phage head begins to be assembled.
Assembly may be initiated by polymerization of gp10 around the scaffolding
protein gp9 to generate an incomplete prohead shell. Insertion of the connector-
core complex (gp8-[ gp14+gp15+gp16 ] ) into the shell may then follow (Cerritelli
and Studier, 1996). Alternatively the connector-core complex may serve to
nucleate assembly of the scaffolding and capsid protein. During this process, gp8
would be added to one vertex of the icosahedral procapsid to form the portal.
Concurrent with the maturation of the procapsid, DNA packaging initiates from a
genomic right end and proceeds leftwards in a process whose details are not well
11
understood. A series of reactions is necessary in order to duplicate the terminal
repeat sequence of T7 DNA that in concatemers is present in only one copy
between genomes. A single-strand break is first made in a cruciform generated
from a palindromic sequence located to the left of the right terminal repeat (Chung
et al., 1990). The resulting hairpin end is used to initiate DNA synthesis as a
leading strand of a bi-directional replication fork. This fork could then proceed
rightward through the terminal repeat and into the genome being packaged,
thereby providing duplex DNA that can be converted into a mature left end. On the
remaining concatemeric DNA, primase-initiated synthesis on the displaced strand
could proceed through the terminal repeat providing sequences that can be
converted into the mature right end of the next genome to be packaged. Gp18 and
gp19 are required to create both the right end and, after packaging, the mature left
end. However, the nuclease that recognizes the termini of mature T7 DNA in a
concatemer is not yet known. During DNA packaging, the procapsid undergoes
structural changes into an expanded icosahedral form. The scaffolding protein gp9
is thought to leave the procapsid at this stage. Once the DNA is completely
encapsidated, the conical tail is attached to the portal structure. In contrast to many
other phages, the T7 tail is assembled on the mature head and does not form an
independent structure. Six tail fibers, each consisting of gp17 trimers, are then
attached to the sides of the tail (Studier, 1972; Roeder and Sadowski, 1977). By 15
min post-infection at 30˚C, the first mature phage particle becomes detectable.
12
The process of cell lysis is poorly understood. Genes 3.5 and 17.5 are
known to be required. Gp17.5 appears to be the holin and may disrupt the
membrane to form cell ghosts, allowing access of gp3.5 amidase to the
peptidoglycan where it can effect lysis (Young, 1992).
Abortive infection of T7 in F plasmid containing hosts
Bacteriophage T7 cannot undergo a productive infection in cells harboring
the F plasmid (Makela et al., 1964). T7 is therefore described as a “ female-
specific” phage and the failure to grow in F-containing (male) bacterial strains is
now referred to as F exclusion. Early stages of the abortive infection are normal:
the phages adsorb to male and female cells with equal efficiency, the first half of
the T7 genome enters normally, the phage DNA is not degraded, and class I
proteins are synthesized normally. However, the infection become grossly aberrant
starting about 8 min after infection. Only half of the infecting phages complete
genome translocation into male cells (Garcia and Molineux, 1995b), transcription
rates of class II and III genes are rapidly reduced and synthesis of class II and III
proteins is severely inhibited. Infected male cells also exhibit a loss of membrane
integrity; as a result, acid-soluble phosphorus-containing compounds, most notably
nucleoside triphosphates, and other small ions leak out of the abortively infected
cell. Cells also fail to accumulate amino acids and become permeable to O-
nitrophenyl-b -D-galactoside (Britton and Haselkorn, 1975a, b; Condit and Steitz,
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1975; Condit, 1975). Host DNA is not completely degraded and no phage DNA
synthesis is detectable. Finally the infected cells die but do not lyse. The numerous
defects that accompany this abortive infection have made it difficult to separate the
primary cause of phage exclusion from secondary or subsequent effects. Intensive
studies have been conducted to elucidate the primary cause of the T7 abortive
infection. However, there is still no agreement as to its cause.
Malamy and co-workers first reported that only class I proteins were
detected during the abortive infection even though RNA isolated from both male
and female T7 infected cells appeared identical (Morrison and Malamy, 1971).
However, Whitaker et al (1975) noted that late T7 mRNAs were present, albeit in
decreased amounts, in infected male cells. Beck and Molineux (1991) later
confirmed that in infected male cells synthesis of late mRNAs was inhibited and
that inhibition was more severe for RNAs transcribed from DNA near the right end
of the genome. This observation became understandable when  further evidence
was provided showing that about half of infecting phages failed to translocate their
entire genome into the cell (Garcia and Molineux, 1995b). In addition, by
measuring the accumulation of early and late proteins, Yamada and Nakada (1975)
and Blumberg et al. (1976) concluded that the translation machinery isolated from
T7-infected male cells exhibited a decreased rate of protein synthesis. They
postulated that the inhibition of translation led to the abortive infection of T7 in
male host cells. However, others reported that no defect could be found in the
14
translational machinery isolated from infected male cells (Condit and Steitz, 1975;
Ponta et al.,1975; Young and Menard, 1975).
Several investigators hypothesized that the change of membrane
permeability is probably the cause of the abortive infection (Condit and Steitz,
1975; Britton and Haselkorn, 1975a). However, T7 mutants that grow normally in
male hosts still cause nucleotide leakage from the infected cells (Molineux et al.,
1989; Schmitt et al., 1991b), though perhaps at lower rates or only at later times
than normal. Furthermore, chromosomal mutations that suppress F exclusion do
not prevent leakiness (Remes and Elseviers, 1980; Schmitt et al., 1991b; Wang et
al., 1999). Thus, membrane leakiness is a phenomenon that may be closely
associated with F exclusion but it cannot be the primary cause.
F pifA
Morrison and Malamy (1971) defined the genes of F that cause T7 to abort
an infection as pif, for phage inhibition factor. They concluded that pif included at
least two genes, pifA and pifB. A new gene, pifC, was identified later and its
product shown to negatively regulate the expression of the pif operon (Miller and
Malamy, 1983). Expression of pifC from a plasmid does not prevent T7 growth but
it does inhibit conjugal transfer of the broad-host-range plasmid RP4 (Cram et al.,
1984; Miller and Malamy, 1983; Tanimoto and Iino, 1989).
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PifA encodes an 80 kDa protein and mutations in pifA abolish F exclusion
of T7 (Rotman et al., 1983). Further evidence showed that a plasmid expressing
pifA as the only F gene inhibited T7 growth, suggesting that pifA is the only F gene
responsible for F exclusion (Schmitt and Molineux, 1991). No biochemical
function has been ascribed to PifA. The very existence of pifB was very
controversial; it is now established that no such gene exists. DNA sequencing of
the putative pifB region showed no open reading frame that could correspond to
the hypothetical PifB. Mutations that were supposed to define pifB are likely to be
leaky pifA mutations.
Phage mutants that grow in male cells
1. T3 mutants
T3 and T7 are closely related phages and exclude each other in co-
infections. They have comparable patterns of RNA and protein synthesis, their
genetic maps have been aligned (Beier and Hausmann, 1973) and the sequence of
the T3 genome is now known to be about 75% identical to that of T7. However, T3
possesses a distinct property: an ability to grow normally in male strains. This
interesting observation led to its employment as a model to investigate the
mechanism of F-exclusion of T7. Early studies of a T3-T7 recombinant revealed
two regions of T3 DNA that were necessary for the hybrid phage to grow in male
strains (Molineux et al., 1983; Spence et al., 1983). One of these regions included
16
T3 genes 1.1 and 1.2, which were shown to function in trans and complement the
defects that caused T7 to be excluded by F (Spence et al., 1983). Mutants of T3,
altered only in gene 1.2, were found to be restricted on male cells and behave like
wild type T7 (Spence and Molineux, 1984). These observations indicate that T3
gene 1.2 is important in suppressing the inhibition by F and, conversely, that T7
gene 1.2 is defective in this activity.
Pseudorevertants of a T3 gene 1.2 deletion mutant able to plate efficiently
on male cells were subsequently isolated. All pseudorevertants contain at least two
mutations in gene 10 (encoding the major capsid protein), suggesting that gene 10
is responsible for F exclusion of a T3 gene 1.2 mutant. It was suggested that the
mutations in gene 10 caused a reduction in the rate of gp10 synthesis, and thus a
reduction in toxicity to the infected male cell (Condreay and Molineux, 1989).
Evidence was also provided that wild type capsid protein (gp10) exerted its
toxicity without being assembled into procapsids. The idea developed that
expression of gene 10 was toxic to cells containing F and that the function of T3
gene 1.2 was to alleviate toxicity and allow phage growth.
2. T7 mutants
The successful characterization of T3 gene 1.2 pseudorevertants that are
resistant to F exclusion led to the construction of T7 mutants able to overcome
exclusion by F (Molineux et al., 1989). These T7 mutants necessarily contain
either a missense or null mutation in gene 1.2 and at least two missense mutations
17
in gene 10. Expression of the wild type allele of either gene 1.2 or 10 results in T7
exclusion by F. The double null mutant of gene 1.2 and 10 does not show any of
the physiological defects associated with the abortive infection (Beck and
Molineux, 1991). Thus the products of gene 1.2 and gene 10 are the targets for
pifA. It is not known how gp10 and gp1.2 exhibit their toxicity on pifA+ cells or
how T7 mutants escape F exclusion. However, mutations in T7 gene 10 are
believed to manifest their effects through the same mechanisms as those in T3
(Condreay et al., 1989; Molineux et al., 1989). The mutations in genes 1.2 and 10
may reduce the toxicity of gp1.2 and gp10A by altering their interaction with
either PifA or a cellular function.
Plasmids expressing wild-type T7 gene 1.2 or gene 10 of either T3 or T7
transform male strains at very low efficiency, relative to the isogenic female strains
(Schmitt and Molineux, 1991). In the presence of pifA, controlled expression of
either wild-type T7 gene 1.2 or gene 10 from plasmids result in the same
physiological dysfunctions associated with the abortive phage infection. Plasmids
containing missense alleles of T7 gene 1.2, obtained from phages that grow in the
presence of F, transform male cells with moderate to high efficiency (Schmitt and
Molineux, 1991). Furthermore, overexpression of the same mutant T7 gene 1.2
from a high copy plasmid allows wild-type T7 to grow in male cells. Thus high
levels of mutant T7 gp1.2 in the cell prior to infection prevent not only phage-
encoded wild-type gp1.2 but also gp10 from interacting with PifA. However,
18
mutant gene 1.2 does not provide this activity when expressed from the phage
genome (Molineux et al., 1989). In contrast, the presence of a single copy of T3
gene 1.2 in a T7 genome is sufficient to allow escape from F exclusion (Garcia and
Molineux, 1995a). These observations suggest that T3 gp1.2 and mutant T7 gp1.2
may work similarly to prevent wild-type T7 gp1.2, and also gp10, from triggering
the abortive infection, except that T3 gp1.2 is more efficient.
Phage genes involved in F exclusion
1. Gene 1.2
Gene 1.2 is located near the primary replication origin of T7 or T3 (Saito et
al., 1980; Dunn and Studier, 1983). It is transcribed early by E. coli RNA
polymerase and late by the phage RNA polymerase. The ribosome binding site of
T7 (but not T3) gene 1.2 is normally embedded in a hairpin structure within the
gene 1.1 coding sequence and translation of gene 1.2 is dependent on translation of
gene 1.1 (Saito and Richardson, 1981).
In addition to its role in F exclusion, a distinct function of gene 1.2 is
known. Gene 1.2 is essential for T7 DNA replication in E. coli strains carrying the
optA1 mutation, which causes the overproduction of cellular dGTP
triphosphohydrolase (dGTPase) (Beauchamp and Richardson, 1988). Gp1.2 has
been shown to specifically inhibit E. coli dGTPase by a reversible association with
an apparent stoichiometry of two gp1.2 monomers to one dGTPase tetramer
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(Huber et al., 1988). T3 gp1.2 has also been shown to inhibit E. coli dGTPase. T7
1.2 mutants are unable to grow on optA1 strains due to the decreased pool of
intracellular dGTP caused by the high levels of dGTPase. The primary sequences
of T7 and T3 gp1.2 share 40% identity.
2. Gene 10
Gene 10 of T7 and T3 codes for two proteins, gp10A and gp10B. Gp10B
contains a C-terminal extension that is produced by a shift to the -1 reading frame
near the normal gene 10A termination codon (Dunn and Studier, 1983; Condreay et
al., 1989; Condron et al., 1991). Gp10A is the major capsid component even
though both gp10A and gp10B are assembled into wild type phage particles. Either
protein alone is sufficient for viability. The primary sequences of T3 and T7
gp10A are 79% identical, but there is no similarity in the C-terminal extensions of
gp10B (Condreay et al., 1989). Distinct from its structural role, synthesis of either
gp10A or gp10B in male cells triggers the abortive infection (Molineux et al.,
1989; Schmitt and Molineux, 1991).
Host mutations that affect F exclusion
FxsAp109
An E. coli mutant was isolated by selecting survivors of co-expressed gene 10A
and pifA (Wang et al., 1999a). The mutant allows T7 to plate at normal efficiency
in the presence of F; the strain contains a promoter-up mutation in fxsA (fxsAp109)
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that causes 25-fold overexpression of fxsA. Increased synthesis of FxsA, a
cytoplasmic membrane protein, alleviates the inhibition of T7 growth by F (Wang
et al.,1999b). Defects in both late phage protein synthesis and the host membrane
integrity persist at reduced levels, but T7 grows moderately well in fxsAp109
mutants that contain F. Disruption of fxsA+ does not abolish the toxicity of the
combination of PifA and either T7 gp1.2 or gp10, and it was suggested that FxsA
plays a protective role, rather than being directly involved in the biochemical
pathway of F exclusion.
 Several other mutants of E. coli, originally isolated for other purposes,
have also been found to affect the F mediated abortive infection of T7. In general,
the mutations in these strains confer pleiotropic phenotypes and many of them
change the severity of F exclusion of T7 simply by altering the level of PifA
expression. Unfortunately, these mutants have not helped to illuminate the
mechanism of T7 exclusion by F. The genes affected include strA (rpsL)
(ribosomal protein S12), galU (UTP a -D-glucose-1-phosphate uridyltransferase)
rho (transcription termination factor), himA (integration host factor IHF), gyrA
(DNA gyrase), and rpoB (RNA polymerase b  subunit).
strA and rpoB
Chakrabarti and Gorini (1975) reported that specific mutations conferring
streptomycin resistance (SmR) in an Hfr strain of E. coli increase the plating
efficiency of T7 by several orders of magnitude. Some SmR derivatives are
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completely permissive for T7, others plate T7 at reduced efficiencies and yield
small plaques, and yet others remain fully restrictive. Subsequently, the same
authors made the even more interesting observation that the effects of these strA
mutations on F exclusion could be reversed by mutations (rpoB) that confer
resistance to rifampin (Chakrabarti and Gorini, 1975). However, these rpoB
mutations have no effect on phage growth in the absence of the strA mutation.
Schmitt et al. (1995) showed that the mutations in strA that allow T7 to
grow in strains containing F reduce the level of expression of a pifA-lacZ fusion,
whereas those rpoB mutations that reversed the effect of the strA mutations
increased expression. This suggests that the rpsL and rpoB mutations exert their
effects on F exclusion of T7 merely by controlling synthesis of PifA. The rpsL
mutations that alleviate F exclusion were also shown to slow the speed of ribosome
movement (Galas and Branscomb, 1976; Zengel et al., 1977). It is also believed
that a slower rate of translation might uncouple the ribosome from RNA
polymerase and allow an increased frequency of Rho-dependent transcriptional
termination (Imamoto et al., 1970) or allow increased nucleolytic degradation of
mRNA not protected by ribosomes (Rosenberg and Schlessinger, 1982). Either
process could also result in lower level expression of pifA.
Gyr, rho, himA and galU
Male strains containing either the rho-702(Ts) or gyrA43(Ts) mutation
were found to allow moderate T7 growth (Schmitt et al., 1995). At permissive
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temperatures for the Ts mutation the gyrA43 mutation increases the plating
efficiency of T7 in male cells, relative to the gyrA+ male parent, by at least seven
orders of magnitude. In addition plaques are almost normal. At 37° C
b –galactosidase activity produced from the pifA-lacZ fusion plasmid is
substantially reduced by the gyrA43 mutation in both exponential and stationary
phases of growth. Therefore, male cells containing the gyrA43 mutation are likely
to be phenotypically PifA-. However, the mechanism by which the gyrA43
mutation affects expression of pifA remains unknown.
E. coli rho mutants have extremely pleiotropic phenotypes. rho mutations
affect transcription termination, recombination, sensitivity to UV irradiation, and
DNA superhelicity (Arnold and Tessman, 1988; Arnold et al., 1989; Guarente and
Beckwith, 1978; Das et al., 1976). At both 30˚ and 37° C, the rho-702 mutation
increases the plating efficiency of T7 in male cells by at least 4 orders of
magnitude (Schmitt et al., 1995). The plating efficiency of T7 in male cells
containing the rho-702 mutation is improved by at least 7 orders of magnitude at
43° C, a temperature at which the host is still viable but contains reduced Rho
activity. b -Galactosidase activities produced from a pifA-lacZ fusion plasmid in
rho-702 cells are similar to those produced in rho+ cells. This result indicates that a
reduction of PifA synthesis is not a major reason for the alleviation of F exclusion
in rho mutants. However, it was suggested that the rho-702 mutation might alter
expression of an E. coli protein that is more directly involved in the biochemistry
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of F exclusion because normal development of T7 does not require Rho (Schmitt et
al., 1995).
Kennedy et al. (1988) reported that mutations (himA or himD) in IHF
increased the plating efficiency of T7 on male strains. Construction of a pifC-galK
promoter fusion to measure galactokinase levels in IHF mutant strains showed that
promoter activity decreased about two-fold. It was proposed that the absence of
IHF alters DNA conformation such that not only is the activity of the pif promoter
reduced but also repression by PifC at pifO is enhanced.
Mutations in galU were also shown to decrease the inhibition of T7 by F
(Remes and Elseviers, 1980) but the mechanism of suppression is not understood.
It was suggested that the lack of UTP a -D-glucose-1-phosphate uridyltransferase
causes an altered lipopolysaccharide that in turn might cause T7 to enter the host
through altered receptors. It was further suggested that F-mediated inhibition might
depend on the attachment and entry process.
Unfortunately none of the proteins encoded by these genes directly
participates in the F exclusion pathway. Although FxsA protects T7 from
exclusion by F and the mutant containing fxsAp109 was obtained for the purpose
of finding cellular components directly affected by the F exclusion system, it does
not play a direct role. Gp1.2, gp10 and PifA are the only known proteins that are
directly involved in F exclusion.
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In this study both genetic and biochemical approaches were employed in
the hope of identifying the cellular target of the F protein PifA, T7 gp1.2 and
gp10A, and of obtaining direct evidence for interactions among those toxic
proteins. The data presented below provide us with a better understanding of the
molecular basis underlying F exclusion of T7.
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Chapter 2.    Materials and Methods
E. coli strains, phage strains and plasmids. These are listed in Tables 1and 2.
Media and antibiotics
L-broth was usually used for bacterial growth, each liter of L-broth
contains 10g Bacto-Tryptone, 5g Bacto-Yeast extract, 5g NaCl (Miller, 1972).
Phage titering usually employed T broth. T broth contains 10g Bacto-Tryptone and
5g NaCl per liter. Plates were made with broth containing 1.5% Bacto-agar; 0.7%
Bacto-agar dissolved in T broth was used to make T-soft agar. MacConkey plates
were made with Bacto-MacConkey base agar supplemented with 1% sugar. One
liter of M9 minimal medium is composed of 1g NH4Cl, 1mM MgSO4, 3g KH2PO4,
6g NaH2PO4 and 2g sugar, usually glucose (Studier, 1969). The following
antibiotics were used: ampicillin (100 µg/ml), kanamycin (25 µg/ml), tetracycline
(20 µg/ml) and chloramphenicol (40 µg/ml).
Enzymes
Restriction endonucleases, T4 DNA ligase, the large fragment (Klenow) of
E. coli DNA polymerase I, and T4 DNA polymerase were from New England
Biolabs. Calf intestinal alkaline phosphatase (AP) and Proteinase K were from
Boehringer Mannheim. Taq DNA polymerase was a gift from Dr. J. J. Bull.
Growth of T7
Mid-log cells of a permissive strain were infected with a small stock of
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Table 1.   Bacterial and phage strains used in this work
Strains           Genotype Sources of references 
BL21(DE3)       F- ompT gal dcm lon hsdSB (l D69 int: T7 gene 1)           Studier et al.,  1990
CAG18493        MG1655 zbi-29::Tn (17.7’)                                            Nichols et al., 1998
CC118               araD139 (ara-leu)7697  lacX74 phoA20                    Manoil& Beckwith,1985
                          galE galK thi rpsE(S cR) rpoB(RifR) argE(Am) recA1
IJ511                  lacX74 galK2 galT22 supE44 hsdS                                 Condreay & Molineux,1989
IJ512                 IJ511 F’lac (F42)
IJ1023               IJ1198  fxsA::Kn                                                              Wang et al., 1999
IJ1029               IJ1198  fxsA::Cm                                                              Wang et al., 1999
IJ1198                lacX74 galK150(Am) cys(Am) Trp(Am) supF             Wang et al., 1999
IJ1199               IJ1198 fxsAp109                                                           Wang et al., 1999
IJ1200               IJ1198  (srlR-recA)306::Tn10                                        Wang et al., 1999
IJ1291               IJ1199 fxsA::Cm                                                                  Wang et al., 1999
IJ1818               IJ511 pnp::Tn5                                                                    This work
IJ1819               IJ512 pnp::Tn5                                                                    This work
IJ1820               IJ1198 T5R                                                                          This work
IJ1821               IJ1199 NalR                                                                          This work
TB1                  ara D (pro-lac) strA thi (F 80d lacZ M15) hsdR                  Yanisch-Perron, et al.,
                                                                                                                        1985
Top10                F- mcrA D (mrr-hsdRMS-mcrBC) [F 80d LacZ M15]          Invitrogen Co.
                          D lacX74 deoR recA1 araD139 D (ara-leu)7697
                          galU galK rpsL (StrR) endA1 nupG
Bacteriopages
T3
 D  2                   T3 D  (1.05-1.2)                                                                      Schmitt et al., 1987
T7
T7+                    Wild type (F. W. Studier)
ST16                  Deletion of T7 genes 1.1 and 1.2                                         Meyer et al., 1987
MM10               10A2D 10A228G                                                                Molineux et al., 1989
MM20               1.2 W31C 10A2D 10A228G                                                    Molineux et al., 1989
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l 1.2pifK           l gt11S+, T7 gene 1.2 and pifA(Am), cI857, KnR                   Wang et al.,  1999
                          under lac promoter  control.
l 10pifK            l gt11S+, T7 gene 10 and pifA(Am) cI857, KnR                     Wang et al.,  1999
                          under lac promoter  control
434-1.2pifA      Recombinant between imm434 cIts56plac5 and l 1.2pifK     Wang et al., 1999
434-10pifA       Recombinant between imm434 cIts56plac5 and l 10pifK      Wang et al., 1999
Table 2.  Plasmids used in this work
 Plasmids                            Features                                                            Source or reference
T7 gene 1.2 plasmids
pAK25          pUC9; T7 gene 1.2 under Plac control.                                     Schmitt, et al., 1991
pCS5             pUC19; T7 gene 1.2 W31C under Plac cont                             Garcia  et al., 1995
pGST1.2       pGEX-3X,  gst-T7 1.2  under Plac cont                                     This work
pGX100        pET-11d, T7 1.2 under T7 promoter control.                             This work
pGX105        pHE11; T7 1.2Y28N  under T7 promoter control                      This work
pGX106        pHE11; T7 gene 1.2W31C under T7 promoter                         This work
pGX107        pHE11; T7 gene 1.2 under T7 promoter control.                       This work
pGX109        pHE11; T7 gene 1.2R37G under T7 promoter control.              This work
pHis1.2         pTrchisA; his-tagged T7 1.2 under Ptrs control.                        This work
T7 gene 10 plasmids
pET10         pET-11d; T7 10A+ under T7 promoter control.                         This work
pET10PC    pET11d; T7 10A A2D,F291S(Ts) under T7 promoter control.    This work
pET10JT     pET11d; T7 10A A2D,A228G(Ts) under T7 promoter control.   This work
pHis10A      pTrchisB; his-tagged T710A under Ptrc control.                         This work
pPK13          pUC19, T7 10Aunder Plac.                                                  Lab collection
pWSK10A   pWSK29,  T7 10A under Plac.                                                 This work
pifA plasmids
pGX25          pTrchisB; truncated pifA (del 1-462) expressing                        This work
                      C-terminal 254 codons.
pGX26           pTrchisB; truncated pifA ( el 1-462) expressing.                      This work
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                       C-terminal 536 codons
pGX31           pTrchisA;   pifA K59A under Ptrc control.                                 This work
pHispifA        pTrchisA;   his-PifA under Ptrc control.                                    This work
pPK5              pKS+; pifC and pifA under Plac.                                                 Lab collection
 fxsA plasmids
pGSTFxsA-C   pGEX-3X; truncated fxsA expressing C-terminal 37 codons    This work
                          fused to gst.
pHisFxsA         pTrchisB; his-FxsA under Ptrc control.                                     This work
pHisFxsA102   pTrchisA; N-terminal 102 residues of FxsA.                             This work
pHisFxsA107   pTrchisA; N-terminal 107 residues  of FxsA.                    This work
pHisFxsA111   pTrchisA; N-terminal 111 residues of FxsA.                             This work
pHisFxsA115   pTrchisA; N-terminal 115 residues of FxsA.                             This work
pHisFxsA121   pTrchisA; N-terminal 121 residues of FxsA.                             This work
pWF184           pWSK29, 725bp TaqI of fxsAp109                                            Wang  et al.,
                         under Plac.                                                                                 1999
pWF185           pWSK29, 725bp TaqI of fxsA+  under Plac.                               Wang  et al.,
                                                                                                                              1999
pFxsA18          pSWFII, C-terminal deletion FxsA fused to PhoA at                  Wang, 1998
                         codon S18, under PfxsA+
pFxsA24          pSWFII, N-terminal FxsA fused to PhoA at codon A24,            Wang,1998
                         under PfxsA+
pFxsA32          pSWFII, N-terminal FxsA fused to PhoA at codon T32,             Wang,1998
                         under PfxsA+
pFxsA40          pSWFII, N-terminal FxsA fused to PhoA at codon S40,              Wang,1998
                         under PfxsA+
pFxsA45          pSWFII, N-terminal FxsA fused to PhoA at codon S45,              Wang,1998
                         under PfxsA+
pFxsA47          pSWFII, N-terminal FxsA fused to PhoA at codon V47,              This work
                         under PfxsA+
pFxsA53          pSWFII, N-terminal FxsA fused to PhoA at codon T53,              Wang,1998
                         under PfxsA+
pFxsA68          pSWFII, N-terminal FxsA fused to PhoA at codon P68,              Wang,1998
                         under PfxsA+
pFxsA77          pSWFII, N-terminal FxsA fused to PhoA at codon S77,               This work
                         under PfxsA+
pFxsA84          pSWFII, N-terminal  FxsA fused to PhoA at codon L84,               This work
                         under PfxsA+
pFxsA88          pSWFII, N-terminal FxsA fused to PhoA at codon P88,                Wang, 1998
                         under PfxsA+
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pFxsA95           pSWFII, N-terminal FxsA fused to PhoA at codon L95,              This work
                          under PfxsA+
pFxsA102         pSWFII, N-terminal FxsA fused to PhoA at codon P102,             This work
                          under PfxsA+
pFxsA122         pSWFII, N-terminal FxsA fused to PhoA at codon P122,             This work
                          under PfxsA+
miscellaneous
pBH176             pBR322; expressing his-tagged SP6 RNA polymerase                 McAllister et al.,
                           of SP6 under T7 promoter control.
pET-11d            pBR322; T7 promoter  expression vector.                                     Studier et al.,
                                                                                                                                 1990
pGEX-3X          pBR322; GST fusion vector; tac p omoter.                                  Pharmacia Biotech
pHE11h             pET11-c; N-terminal his-tag vector under T7                                Harshey lab
                          promoter control.
pLys(S)             pACYC184; synthesizing T7 lysozyme.                                       Studier  et al.,
                                                                                                                                 1990
pPK41               pACYC184, T7 RNA polymerase gene 1.                                   Lab collection
pQ                     pACYC184::lacIQTcR                                                                                Lab collection
pSWFII             pBR322, signal-less & promoter-less phoA.                                Ehrmann et al., 1990
pTrchisA,B,C    pBR322, N-terminal his-tag vector, under Ptrc.                          Invitrogen
pTrcPNP           pTrc99A, synthesizing C-terminal his-PNPase under Ptrc         This work
pTrc99A            pBR322, C-terminal his-tag vector, under Ptrc.                          Pharmacia Biotech
pWSK29           pSC101 replicon, cloning vector.                                                 Wang  et al., 1991
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phage and the culture was incubated aerobically at 30˚C until lysis. The lysate was
made 1M NaCl by the addition of solid NaCl and cell debris was removed by
centrifugation at 10,000 rpm for 15 min; phage stocks were stored at 4˚C. When
purified phage was required, the lysate was made 6% polyethylene glycol 8000
and stored at 4˚C overnight. Phages were collected by centrifugation at 5000 rpm
for 10 min. After resuspension in T7 buffer (10 mM Tris-HCl, pH 8.0, 0.1mM
EDTA, 1M NaCl) and a brief centrifugation, phages were loaded onto a 3-layer
step gradient of CsCl (33g, 41g, and 50g per 50 ml H2O; r  = 1.35, 1.45, and 1.55)
and centrifuged at 35K in a Beckman SW55 rotor for 2 hr. Phages were collected
through the side of the tube with a syringe, dialyzed against T7 buffer, and stored
at 4˚C.
Preparation of plasmid DNA
Plasmid DNA was prepared by an alkaline lysis procedure adapted from
the protocol in Molecular Cloning (Maniatis et al., 1989). An overnight culture
(1.5 ml) of cells carrying the plasmid was centrifuged and suspended in 0.1 ml
solution I (50 mM glucose, 10 mM EDTA, 25 mM Tris-HCl, pH 8.0). Two
volumes of solution II (0.2M NaOH, 1% SDS) were added. After incubation for 5
min, the cell lysate was neutralized by addition of 1.5 volumes of solution III (3M
NaOAc, pH 4.8) and incubated on ice for 5 min. After removal of cell debris by
centrifugation, the supernatant was precipitated with 2 volumes of 95% ethanol.
Plasmid DNA was dissolved in either H2O or TE buffer (10 mM Tris-HCl, 1mM
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EDTA, pH 8.0), treated with RNase (100µg/ml) and extracted with
phenol/chloroform/isoamyl alcohol (25:24:1). After a brief centrifugation, the
aqueous layer was precipitated with 2 volumes of 95% ethanol. Plasmid DNA was
washed with 70% ethanol, dried and resuspended in TE or in H2O. The
concentration of DNA was determined by measuring A260 using the formula:
[ DNA ]  = A260 x 50 µg/ml.
Plasmid construction
Where PCR was part of a construction, the relevant parts of the final
plasmid were sequenced to confirm their structure.
1. pGX100: T7 gene 1.2 was amplified by PCR using primers Nco I-1.2T7-6137F
(5´–AGCTCCATGGGACGTTTATATAGTGG) and T7 6397R
(5´–GCGGATCCACGTATTACTTCCAGTCC). The amplified gene is flanked by
Nco I and BamH I sites. After digestion with Nco I and BamH I, gene 1.2 was
cloned into pET-11d (Nco I/BamH I). This yielded pGX100 in which gene 1.2 is
under T7 promoter control.
2. pGST1.2: pGEX-3X, a glutathione S-transferase (GST) fusion vector, was used
as a backbone to construct pGST1.2. pGEX-3X is a pBR322 derivative and
contains the coding sequence for GST protein (26 kDa) under the control of the
IPTG-inducible tac promoter. T7 1.2 gene was amplified by PCR using T7 DNA
as a template. Primers 1.2T7 F (5´–ATGCAGATCTGGGTCAGTAAGATGGG )
and T7 1.2-6397Ra (5´–GCGGATCCACGTATTACTTCCAGTCC) were
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designed such that the amplified gene 1.2 was flanked by Bgl II and BamH I
restriction sites. After digestion with BamH I and Bgl II, the amplified 1.2 gene
was cloned into the BamH I site of the polylinker of pGEX-3X. This produced the
plasmid pGST1.2 with gene 1.2 fused, in-frame, to the 3´ of gst.
3. pGX107: T7 gene 1.2 was amplified by PCR from T7 DNA using the primers,
Nco I-1.2T7-6137F (5´–AGCTCCATGGGACGTTTATATAGTGG) and BamH I-
1.2T7-6397Ra (5´–GCGGATCCACGTATTACTTCCAGTCC). The amplified
gene 1.2 was flanked by Nco I and BamH I restriction sites. After gel purification
and cleavage with Nco I and BamH I, gene 1.2 was cloned into pHE11h,
previously digested with the same enzymes. The resulting plasmid pGX107
contained gene 1.2 under T7 promoter control, allowing inducible synthesis of a
gp1.2 derivative with a N-terminal hexahistidine tag in E. coli strain BL21(DE3).
Plasmids (pGX105, pGX106 and pGX109) expressing his-tagged T7 mutant gp1.2
were constructed by the same procedure.
4. pET10A: T7 gene 10A was excised from pPK13 with Nhe I-BamH I and
inserted into the polylinker of pET-11d cut with same enzymes creating pET10A.
Expression of gene 10A is under T7 promoter control and inducible with IPTG.
5. pHis10A: pPK13 containing T7 gene 10A was cut with Nde I, made blunt-ended
with Klenow fragment and digested with EcoR I to yield a Nde I (fill-in)-Eco RI
gene 10A fragment. The fragment was cloned into pTrchisB (N-terminal his-tag
vector) digested with Bgl II (Klenow fill-in) and Eco RI to yield pHis10A from
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which the N-terminal his-tagged 10A gene was expressed under trc promoter
control.
6. pHisPifA: a 2.4 Kb Bgl II DNA fragment containing the complete pifA gene
was excised from pPK5 and inserted into the Bgl II site of pTrchisA, a N-terminal
six histidine-tag vector. The resulting plasmid (pHisPifA) expresses a tagged PifA
under the control of the trc promoter.
7. pHisFxsA: A Hinc II fragment containing fxsA from pWF185 was ligated into
the Bgl II site (blunt ended by a fill-in reaction with Klenow fragment) of
pTrchisA. Expression of fxsA is under trc promoter control.
8. pGSTFxsA-C: A DNA fragment (Hinc II-Sph I of fxsA, 111 bp) was excised
from pWF185 and inserted into Sma I site of pGEX-3X. The construct expresses
the last 37 amino acids of FxsA (residues 122-158) fused in frame to the C-
terminus of GST.
9. FxsA-phoA plasmids: All fusions were constructed by ligating PCR products of
various N-terminal coding sequences of fxsA into the promoter-less, signal
sequence-less phoA plasmid pSWFII at the unique Sma I site (Ehrmann et al.,
1990). Transcription of the fusion gene is from the fxsA+ promoter. pSWFII is a
pBR322-based replicon of medium copy number.
10. pTrcPNP plasmid: The gene encoding E. coli polynucleotide phosphorylase
(PNPase) was amplified by PCR from genomic DNA of the strain MG1655.
Primers PNPNcoI (5’-GCACCATGGCTATGCGCAGAAGATCG) and
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PNPBamH (5’- GCGGATCCTTACTCGCCCTGTTCAGC) are based on the pnp
sequence and the amplified gene is flanked by Nco I and BamH I sites. After
amplification and cleavage with Nco I and BamH I, PCR products were cloned into
pTRC99A digested with Nco I and BamH I. The resulting plasmid pTrcPNP
expresses PNPase under trc promoter control with a C-terminal his-tag.
Selection for E. coli mutants tolerant to coexpression of pifA and gene 1.2 or
10
l 1.2pifK and l 10pifK were used as a primary selecting phages. They are
derivatives of l gt11 lacking the Sam100 mutation. l 1.2pifK contains T7 gene 1.2,
pifA and KnR; l 10pifK contains T7 gene 10, pifA and KnR. These genes are co-
expressed under lac promoter control. The selection for E. coli mutants that
survive a challenge from T7 gene 1.2 or T7 gene 10 and pifA was conducted as
follows. About 2x109 stationary phase IJ1198 cells from each of 5 independent
cultures were treated with nitrosoguanidine (50 µg/ml, 37° C for 10 min) to give
30% survival; following outgrowth cells were infected at room temperature with
l 1.2pifK or l 10pifK at a multiplicity of 10. After removal of unadsorbed phage,
infected cells were suspended in M9 galactose medium and incubated for 60 min at
30˚C. Cells were then plated on M9 galactose agar containing 25 µg/ml
kanamycin. Cell growth thus requires maintenance of supF for suppression of the
three amber mutations (galK, trp, cysI) in IJ11998 and the presence of l 1.2pifK or
l 10pifK to provide Knr. Colonies were purified on the same media and patch-
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tested at 30˚C on plates containing 5x107 434-1.2pifK or 434-10pifK (30˚C is non-
permissive for the 434cI56(Ts) mutation) to screen for non-toxic prophages. 434-
1.2pifK and 434-10pifK are the equivalent phages of l 1.2pifK and l 10pifK except
that the immunity region imm  is substituted with imm434. Only lysogens that
harbor a mutation conferring tolerance to gene 1.2 and pifA coexpression (or gene
10 and pifA) allow lytic growth of 434-1.2pifK (or 434-10pifK). Sufficient
numbers of cells were applied to each patch such that clearing due to phage growth
would be obvious and that confluent growth resulted if the strain could not
propagate the tester phage. Mutants were then tested for their ability to support the
growth of a T4 55(Am) mutant to ensure that supF activity was not reduced.
Cell growth and preparation of cell extracts
For genetic overexpression and purification of proteins, cells were
normally grown at 37˚C to A600 of 0.7-0.8 and induced with 1mM IPTG for 2-3 hr.
Cells were harvested by centrifugation at 5000 rpm for 10 min at 4˚C, resuspended
in either PBS (140 mM NaCl, 2.7 mM KCl, 10mM Na2HPO4, KH2PO4, pH 7.4)
for GST fusion proteins, or 50 mM NaH2PO4 pH 8, 300 mM NaCl and 10mM
imidazole for his-tagged proteins (50 µl per ml of original cell culture), and were
then disrupted by passage through a French pressure cell at 16,000 p.s.i. The cell
lysate was made 10 mM MgSO4 and incubated with 1% Triton X-100 (his-tagged
and GST fusion proteins only), 5 µg/ml DNase and 1mM PMSF at room
36
temperature for 10 to 20 min with occasional mixing. Cellular debris was then
removed by centrifugation at 10,000 rpm for 10 min at 4˚C.
FxsA was prepared from IJ1200/pWF185. Cells were grown at 37 °C to
A600 =1.5, harvested by centrifugation and resuspended in a solution (50 mM
NaH2PO4 pH 8.0, 25 mM NaCl, 10 mM imidazole, 50 µl per ml of original
culture). Cell extracts were made as described above except that Triton X-100 was
added to 0.5% in order to enhance solubilization of FxsA from the membrane.
To prepare wild-type and mutant T7 gp10A, 25 ml of BL21DE3(pLysS)
containing pET10A, p10A-PC10 or p10A-JT4 were grown to A600 = 0.5 and
induced with 1mM IPTG at 30˚C or 37˚C for 2 hr. Cells were resuspended in 5 ml
PBS. Cell extracts were prepared as described above.
Preparation of cytoplasmic and membrane fractions for cellular localization
of proteins
1. Cellular localization of PifA and N-terminal truncated PifA
A 200 ml culture of IJ511/F´lac at A600 = 0.7 was harvested by
centrifugation. Cells were resuspended in 5 ml PBS (pH 7.4) and broken by
passage through a French pressure cell. The total membrane fraction was collected
by centrifugation at 100,000 x g for 2 hr at 4˚C and resuspended in 5 ml PBS (pH
7.4). For the Sarkosyl solubility assay, the total membrane suspension was
incubated on ice with 0.5% Sarkosyl for 10 min and centrifuged at 100,000 x g for
2 hr at 4˚C. After dissolving the pellet in 5 ml PBS, both the pellet suspension and
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the supernatant were dialyzed against PBS (pH 7.4). In some experiments, the
membrane pellet was suspended in 1M NaCl. After incubation with shaking at 4˚C
for 20 min, the membrane was collected as described above. Samples from each
fraction were subjected to SDS-PAGE and examined for the presence of PifA by
immunoblotting using anti-PifA antibody. N-terminal truncated PifA was localized
by the same procedure as above except that Top10(pGX25) and Top10(pGX26)
were the strains used.
2. Cellular localization of T7 gp1.2 and gp10A
A 100 ml culture of IJ1199(Q)(pAK25) at A600 = 0.4 was induced with
0.1mM IPTG until A600 = 0.7-0.8. IJ1199(Q)(pWSK10A) was grown to A600 = 0.7-
0.8 at 37˚C without IPTG induction. Harvested cells were resuspended in 5 ml of
50 mM Tris-HCl pH 8.0 and disrupted using a French press. After removal of cell
debris, cell extracts were centrifuged at 100,000 x g at 4˚C for 2 hr. The total
membrane fraction was suspended in 50 mM Tris-HCl pH 8.0. The presence of
gp10A and gp1.2 in the cytoplasmic and membrane fractions was determined by
SDS-PAGE and immunoblotting using anti-10A or anti-1.2 antibody. Protein
concentrations were measured by using the Bradford reagent (Bio Rad).
Preparation of inner and outer membranes
 Membranes were prepared from strain IJ511/F’lac using the method of
Osborne et al. (1972). A 200 ml culture was grown to a cell density of 5 x 108 per
ml at 37˚C. Cells were harvested by centrifugation at 5000 rpm, resuspended in 10
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ml of an ice cold solution of 0.75M sucrose, 10 mM Tris-HCl (pH 7.8) and
incubated with 100 µg/ml lysozyme for 2 min. Twenty ml of ice-cold 1.5 mM
EDTA (pH 7.5) were then added slowly with gentle mixing over a period of ten
min. Spheroplasts were broken by one passage of the suspension through a French
pressure cell at 16,000 p.s.i. After removal of cell debris by centrifugation at
10,000 rpm for 10 min, crude membranes were collected by centrifugation at
150,000 x g for 2 hr at 4˚C and gently resuspended in 10 ml of 0.25 M sucrose, 3.3
mM Tris-HCl, 1mM EDTA (pH 7.5). After centrifugation at 150,000 x g for two
hr at 4˚C, the membrane fraction was resuspended in 1ml 25% (w/w) sucrose,
5mM EDTA (pH 7.5), and was then loaded on top of a step sucrose gradient (0.5
ml of 55%, 0.7 ml each of 50%, 45%, 40% 35%, and 30% sucrose (all w/w)).
Inner and outer membranes were separated by centrifugation in a SW 55 rotor at
120,000 x g for 14 hr at 4˚C; 250 µl fractions were collected from the tube bottom.
Protein concentration was determined using the Bradford reagent. For assaying the
activity of NADH oxidase, 5 µl of each gradient fraction was incubated with 1ml
of 50 mM Tris-HCl (pH 7.5), 0.12 mM NADH, 0.2 mM dithiothreitol, at 37˚C for
10 min. NADH oxidase activity was measured as the decrease in absorbance at
340nm. Relative amounts of PifA and OmpA in fractions were determined by a
western blot using anti-PifA and anti-OmpA (a gift from Dr. C. Earhart) antibodies
after electrophoresis through a 12% SDS-PAGE gel and electrotransfer of the
proteins to a PVDF membrane.
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SDS-PAGE and Immunoblotting
Proteins were resolved on 12% (gp10A, PifA and FxsA) or 15% (gp1.2)
Tris-glycine SDS-PAGE gels. Proteins were then electrophoretically transferred to
a PVDF membrane (Millipore Co.). After one hour of blocking with 5% nonfat
milk in TBS (20 mM Tris-HCl, 500 mM NaCl, pH 7.5), the membrane was
incubated with primary antibody in TTBS (20 mM Tris-HCl, 500 mM NaCl,
0.05% Tween 20, pH 7.5) for 1 hr and then incubated with a TTBS solution
containing a secondary antibody conjugated with alkaline phosphatase for 1 hr.
Primary antibodies were used at a dilution of 1:10,000 for anti-10A, 1: 5,000 for
anti-PifA, and 1: 3,000 for anti-1.2 and FxsA. Secondary antibodies were diluted
in TTBS at 1: 5,000 for goat anti-rabbit (Bio Rad) and 1:3,000 for goat anti-mouse
(Kirkegard and Perry Lab, Inc). Protein bands of interest were visualized using AP
color reagents from Bio Rad Laboratory.
Quantitative immunoblotting
To quantitate PifA in IJ511/F’lac, 100 ml of cells were grown at 30˚C to late log
phase, harvested and resuspended in 2 ml PBS (pH 7.4). After disruption in the
French press, the cell extract was subjected to SDS-PAGE. Various amounts of
purified his-PifA were also loaded to the same gel to make a standard curve. After
immunoblotting using anti-PifA serum, blots were scanned at 300 dpi and the
digitized images were quantified with NIH Image software. For the quantification
of gp1.2 and gp10A in F- and F+ strains after T7 infection, 300 ml of IJ511 or
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IJ511/F’lac was infected with T7 at a m.o.i. of 0.4 or of 5 when the cell density
reached 2x108 /ml. Infected cells were harvested 20 min after infection and washed
once with PBS (pH 7.4). After resuspension in 1.5 ml PBS, cells were disrupted in
the French press. Cell extracts were subjected to SDS-PAGE followed by
immunoblotting using anti-gp1.2 or anti-gp10A serum. Protein quantification was
as for PifA except that purified gp1.2 or gp10A was used as a standard.
Antibody production
Polyclonal antisera were produced by following the procedure from “Current
Protocols in Molecular Biology” (Struhl et al., 1992). Briefly, purified protein in
PBS (pH 7.4) was mixed and emulsified with an equal volume of complete
Freunds adjuvant (CFA, Sigma). A dose corresponding to 0.5 mg protein was
injected subcutaneously into a female New Zealand rabbit. Booster immunizations
using incomplete Freunds adjuvant were administered three times every three
weeks after the primary injection. The antisera were collected two weeks after each
boost and stored in aliquots as crude serum at –20˚C.
Protein purification
1. GST fusion proteins:
Purification of GST fusion proteins was conducted following the batch
purification protocol from Pharmacia Biotech. GST-1.2 and GSTFxsA-C were
expressed from the strains Top10(pGST1.2) and Top10(pGSTFxsA-C). Cell
extracts were absorbed to glutathione-Sepharose 4B beads (Sigma) (0.5ml beads
41
per 5 ml cell extract) for 2-4 hr at 4˚C with gentle agitation. The beads were gently
pelleted and washed three times with 10 bed volumes of PBS. Bound GST fusion
proteins were eluted with glutathione elution buffer (10 mM reduced glutathione,
50 mM Tris-HCl, pH 8.0), dialyzed against PBS and stored at –20˚C. The purity of
GST fusion proteins was determined after electrophoresis using SDS-PAGE.
2. His-tagged proteins
 His-tagged proteins were purified essentially by using Qiagen’s protocol
for batch purification. His-tagged proteins were expressed from the following
strains: Top10(pHisPifA) for his-PifA, BL21(DE3)(pGX107) for his-1.2,
BL21(DE3)(pGX105) for his-1.2 (Y28N), BL21(DE3)(pGX106) for his-1.2
(W31C), BL21(DE3)(pGX109) for his-1.2 (R37G), BL21(DE3)(pBH176) for SP6
his-RNA polymerase (RNAP), Top10(pHis10A) for his-10A and pTrcPNP for
PNPase-His. A 50% Ni-NTA agarose slurry was added to cell extracts (1ml per 5
ml cell extract) and the mixture was gently shaken at 4˚C for 2-4 hr. The resin was
collected and washed extensively with buffer (50 mM NaH2PO4, pH 8.0, 300 mM
NaCl, 20 mM imidazole). Bound protein was eluted with a step gradient of elution
buffer (50 mM NaH2PO4, pH 8.0, 300 mM NaCl) containing 40, 60, 80 and 250
mM imidazole. The his-tagged protein in each eluate was detected by SDS-PAGE,
fractions containing the purest protein were pooled, dialyzed against 50 mM
NaH2PO4 (pH 8.0), 50 mM NaCl, 10% glycerol and aliquots were stored at –20˚C.
 3. T7 gp1.2
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 1.2 protein was purified essentially as described by Myers (1987).
Preparation of cell extract: Cells from 2 liters of an induced
BL21(DE3)(pLysS)(pGX100) culture were suspended in 100 ml of buffer A (20
mM Tris-HCl, pH7.5, 10% glycerol, 2 mM b -mercaptoethanol, 50 mM NaCl, 0.1
mM EDTA) containing 1mM PMSF, 5 µg/ml DNase and 10mM MgSO4 and were
disrupted by passage through a French pressure cell. The supernatant, after
centrifugation to remove unbroken and cellular debris, is Fraction I.
Streptomycin sulfate precipitation: Eleven ml of 40% freshly dissolved
streptomycin sulfate was slowly added to 110 ml of Fraction I. The solution was
stirred for 30 min and was then centrifuged at 1,600 x g for 30 min. Ammonium
sulfate (38.5 g) was dissolved in 110 ml of the supernatant and the solution was
stirred at 4˚C for 45 min. After centrifugation as above the precipitate was
dissolved in Buffer A and dialyzed against the same buffer (Fraction II).
DEAE-Cellulose: Fraction II was loaded onto a 4.9 cm2 x 21 cm column of DE32
DEAE-cellulose, equilibrated with buffer A. After washing with one volume of
buffer A, the column was eluted using a one liter gradient of 50-500 mM NaCl in
buffer A at a flow rate of 0.5 column volume per hr. Fractions containing gp1.2, as
determined by SDS-PAGE gel analysis, were pooled, concentrated by precipitation
with 80% ammonium sulfate, and were resuspended in 2 ml of buffer B (50 mM
Tris-HCl, pH7.5, 10% (w/v) glycerol, 150 mM NaCl, 0.1 mM EDTA, 2 mM b -
mercaptoethanol) (Fraction III).
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Sephadex G-50: Fraction III was loaded onto a 25cm x 4.9cm2 Sephadex G-50
column equilibrated with buffer B. The column was washed with buffer B at a
flow rate of 12 ml per hour. Fractions containing gp1.2 were pooled as determined
by SDS-PAGE gel analysis, concentrated by dialysis against solid polyethylene
glycol 8000, and were dialyzed against buffer C (7.5 mM potassium phosphate, pH
7.4, 10% glycerol, 2 mM b -mercaptoethanol) (Fraction IV).
Hydroxylapatite: Fraction IV was loaded onto a 7cm x 1.8 cm2 hydroxylapatite
column equilibrated with buffer C. The column was washed with one column
volume of buffer C and gp1.2 was then eluted with a gradient (100 ml) of 7.5-100
mM potassium phosphate (pH 7.4) in buffer C. Fractions containing gp1.2, as
judged by SDS-PAGE, were pooled and dialyzed against buffer D (20 mM Tris-
HCl pH7.5, 0.1mM EDTA, 50% glycerol). Purified gp1.2 was stored at –20˚C.
4. T7 gp10A
1). For antibody production.
T7 gp10A was purified by the method of Hager (1980). Purified T7
particles were electrophoresed on a gradient SDS-PAGE gel (7.5-17.5 %). The
band of gp10A was visualized by staining with 0.25 M KCl and excised. Gel
pieces were soaked in elution buffer (0.1% SDS, 50 mM Tri-HCl, pH 7.9, 0.1 mM
EDTA, 0.15 M NaCl), were crushed with a Teflon pestle, and were agitated at
25˚C for 1 hr. After brief centrifugation, the supernatant was concentrated using an
44
Amicon Centurion 10 filter, dialyzed against PBS containing 0.05% NP-40, and
stored at –20° C.
2). For protein interaction assays.
Cell extract: Gp10A was expressed from BL21(DE3)(pLysS)(pET10A) and cell
extracts were made as described (Cerritelli et al., 1996). Cells were suspended in
1/5 of the original culture volume in buffer E (20 mM Tris-HCl pH 8.0, 3 mM b -
mercaptoethanol, 10% glycerol, 2 mM EDTA, 100 mM NaCl) containing 1mM
PMSF and 0.1% Triton X-100 and disrupted by passing through a French press.
Extracts were then treated with DNase I (10 µg/ml) in the presence of 10 mM
MgSO4 for 15 min at room temperature and were then centrifuged at 5000 rpm for
10 min to remove cell debris.
Ammonium sulfate precipitation: A saturated ammonium sulfate solution was
added to 200 ml cell extract to give a final concentration of 20%. The solution was
stirred at 4˚C for 3 hr and then centrifuged at 3000 x g for 30 min. The precipitate
was dissolved in buffer E and dialyzed against the same buffer overnight at 4˚C
(Fraction I). Proteins in both the supernatant and precipitate were analyzed by
SDS-PAGE.
DEAE-Sepharose: Fraction I was loaded onto a DEAE-Sepharose CL-6B column
(5cm x 5cm2) previously equilibrated with buffer E. As gp10A does not bind to
DEAE-Sepharose, the flow-through was collected and analyzed by SDS-PAGE.
Fractions containing the purest gp10A were pooled and stored at –20˚C.
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Protein interaction assays
1. Affinity chromatography
1). Batch affinity chromatography: 0.5 mg purified his-tagged protein in
0.5 ml of buffer F (50 mM NaH2PO4 pH8.0, 25 mM NaCl) was incubated with
0.1ml of a 50% slurry of Ni-NTA agarose beads equilibrated with buffer F. After
gentle shaking for 2 hr at 4˚C the resin was washed three times with 1.5 ml of
buffer F containing 10 mM imidazole. Centrifugation was used to remove unbound
protein. An additional 0.5 mg of his-tagged protein was loaded onto the beads,
incubated and washed as above. The concentration of bound protein was estimated
by comparing the amounts of starting material and unbound protein. Beads were
usually saturated with the his-tagged proteins used after the second loading; 0.2-
0.3 mg of protein usually bound to the resin.
Ten µg of T7 gp1.2 or gp10A (in 0.5 ml) or 5 ml of a cell extract
containing gp10A, gp1.2 or FxsA in buffer F plus 10 mM imidazole was incubated
with 50 µl (drained volume) of Ni-NTA agarose beads bound with his-PifA or SP6
his-RNA polymerase (his-RNAP). After two hours of gentle mixing at 4˚C the
mixture was washed by centrifugation 5 times using 1.5 ml buffer F plus 20 mM
imidazole. All proteins, including his-tagged protein and any interacting proteins,
were then eluted from Ni-NTA agarose beads with Buffer F (300 µl) containing
250 mM imidazole. To measure binding of FxsA, gp10A and gp1.2 to the
immobilized PifA the resin was eluted stepwise with buffer F containing 50, 100,
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150 mM NaCl. Each step eluate was subjected to SDS-PAGE, proteins specifically
bound to his-tagged protein were analyzed by immunoblotting.
2). Column affinity chromatography:
a). Ni-NTA agarose: 1mg of His-PifA or SP6 his-RNA polymerase
(RNAP) was gently mixed at 4˚C overnight with 0.2 ml of a 50% Ni-NTA agarose
beads slurry in buffer F. After washing three times with 1.5 ml of buffer F, the
resin was equilibrated with 20 mM Tris-HCl, pH 7.5, 10% glycerol, 0.1 mM
EDTA, 0.1 mM DTT (buffer G) containing 25 mM NaCl and 0.5 mg/ml BSA.
Gp10A (0.14 mg) or gp1.2 (0.5 mg) was mixed with 0.1 ml (drained volume) of
PifA or RNAP resin in a total volume of 0.5 ml buffer G containing 25 mM NaCl
and 0.5 mg/ml BSA. After incubation for two hours at 4˚C, the slurry was applied
to a Pasteur pipette tip column. After washing with buffer G containing 25 mM
NaCl and 0.5 mg/ml BSA to remove unbound gp10A or gp1.2, a step gradient of
buffer G containing 50,100, 150, 200,250, 300, 350 or 400 mM NaCl (1 ml for
each concentration) was used, at a flow rate of 1 ml per hr, to elute gp10A or
gp1.2. Elution was performed at room temperature, and fractions of 200 µl were
collected. The presence of gp1.2 and gp10A was monitored using the Bradford
reagent and confirmed by SDS-PAGE.
b). Affi-Gel 10: His-PifA and SP6 his-RNAP were coupled to Affi-Gel 10
as recommended by Bio Rad. Each protein (0.5 mg in 0.25 ml) was dialyzed
against 0.1M MOPS pH 7.5, 0.5 mM EDTA, 10% glycerol, and incubated at 4˚C
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overnight with 0.3 ml of drained Affi-Gel 10 equilibrated in the same buffer. The
resin was then saturated with ethanolamine and washed; coupling efficiency was
80% for his-PifA and 85% for SP6 his-RNA polymerase. Each resin (150 µl) was
then gently mixed with his-tagged mutant gp1.2 (0.5 mg in 0.25 ml) in a total
volume of 0.4 ml of buffer G containing 0.5% BSA at 4˚C for two hr. The resin
was then loaded onto a Pasteur pipette tip column; after washing with buffer G
containing 25 mM NaCl and 0.5 mg/ml BSA, bound mutant gp1.2 was eluted,
collected and detected in the same manner as described above for wild-type gp1.2.
2. Co-immunoprecipitation
1). gp10A and gp1.2 interactions:
Purified gp1.2 (10 µg) was incubated with gp10A (10 µg) or his-PifA (10
µg) in 0.5 ml of 25 mM Tris-HCl pH 8.0, 25 mM NaCl, 0.1% NP-40 at 4 ° C for 6
hr with gentle mixing. Five µl of anti-gp10A or anti-PifA serum was added. After
1 hr 10 µl of a 50% protein agarose bead slurry was then added and incubation
continued at 4° C for 1 hr. The agarose beads were finally collected and washed
with the above buffer. SDS-loading buffer was added to the beads and the mixture
was boiled for 5 min. Soluble materials were subjected to SDS-PAGE and the
presence of gp1.2 was examined by immunoblotting using anti-gp1.2 antibody.
2) PifA-del(1-462) and truncated FxsA interactions:
BL21DE3(pLysS)(pHisFxsA111) was grown in M9 minimal medium
containing 0.2% glucose, 1mM MgSO4, 20 µg/ml vitamin B1 at 37˚C to A600 =
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0.25 and induced with 1mM IPTG for 30 min. Cells were labeled with 10 µCi/ml
of [ 35S ] methionine (1175Ci/mmol) for 5 min and resuspended in 50mM K2HPO4,
pH8.0, 1mM EDTA, 0.1 M NaCl, 0.1% Triton X-100 (100 µl per ml culture) and
then lysed by freezing and thawing twice. After removal of cell debris by
centrifugation, 0.1 ml of the supernatant was incubated with 1 ml of cell extract
containing his-PifA-del(1-462) at 4˚C for 2 hr with gentle mixing. SP6 his-RNAP
was used as a control. Ten µl of anti-PifA serum was added, mixed for 1 hr at 4˚C,
and 50 µl of 33% protein A agarose beads was then added. Incubation was
continued for 1 hr at 4˚C. The agarose beads were collected, washed with 50mM
K2HPO4, pH8.0, 1mM EDTA, 0.1 M NaCl and boiled in SDS-loading buffer for 5
min. Soluble material was subjected to SDS-PAGE and the presence of FxsA was
revealed by phosphorimagery.
3. Binding constant (Kd) assay
Purified gp10A (50 nM) or gp1.2 (100 nM) was incubated with increasing
concentrations of his-PifA in a volume of 100 µl at 4˚C for 2 hours in binding
buffer (25 mM Tris-HCl, pH 7.5, 50 mM NaCl, 10 mM imidazole and 1mg/ml
BSA). Forty µl of Ni-NTA agarose beads were added to each reaction and the
mixture incubated for 1 hr to retrieve his-PifA. The resin was then washed five
times with 1.5 ml ice cold 25mM Tris-HCl, pH 7.5, 100 mM NaCl, 20 mM
imidazole and 0.1% Triton X-100. Bound proteins were eluted with a 25 mM Tris-
HCl, pH 7.5, 250 mM imidazole, 300 mM NaCl solution and were subjected to
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SDS-PAGE. Gp10A or gp1.2 protein was detected by immunoblotting. The
amount of gp10A or gp1.2 that bound to His-PifA in each reaction was determined
by measuring the density of each band using the program NIH image.
35S  labeling of FxsA-phoA fusions
1 ml of CC118 containing a fxsA-phoA fusion plasmid was grown in M9
minimal medium supplemented with 0.2% glucose, 100 µg/ml arginine and
leucine, 20 µg/ml vitamin B1 and 1mM MgSO4, at 37˚C to A600 = 0.3 and pulse-
labeled with 100 µCi/ml of [35S]methionine (1175 Ci/mmol) for 1 min.
Immunoprecipitation was performed as described (Ito, 1981). The cell pellet from
1 ml culture was dissolved in 20 µl of 1% SDS, 50mM Tris-HCl (pH8.0) and 1
mM EDTA and boiled for 2 min. Six hundred and sixty  µl of cold Triton buffer
(2% Triton X-100, 50 mM Tris-HCl, pH8.0, 0.15M NaCl, 0.1 mM EDTA) was
added. After removal of a non-specific precipitate by microcentrifugation for 10
min at 4˚C, the supernatant was mixed with 2 µl of anti-PhoA antibody at 4˚C for
1 hr. Forty µl of 33% protein A agarose beads were then added and the mixture
was incubated at 4˚C for 1 hr. Beads were pelleted, washed twice with Triton
buffer and once with 10mM Tris-HCl, pH8.0, and then were boiled for 2 min in
SDS-PAGE loading buffer. Soluble material was analyzed by SDS-PAGE.
Alkaline phosphatase activity
Alkaline phosphatase activities were measured by a modified procedure of
Brickman and Beckwith (1975). Log-phase cells (1.5 ml) were resuspended in 1
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ml 1M Tris-HCl pH 8.0 and the A600 was measured. Cells were permeabilized by
the addition of 10 µl CHCl3 and 10 µl 10% SDS, and then 50 µl of 80 mg/ml p-
nitrophenyl phosphate (Sigma 104 phosphatase substrate) was added. The reaction
was incubated at room temperature for 10 min and was terminated by the addition
of 100 µl 1M K2HPO4. After removal of cell debris by centrifugation, the A420 of
the supernatant was measured. Activity is calculated as units = 1000 x A420 /(t x
A600), where t = time of incubation (min). All assays were carried out using the
strain CC118 containing a test plasmid. Background values were obtained from the
strain containing the vector plasmid pSWFII and were subtracted from the value
obtained with each PhoA-fusion.
Proteinase K accessibility
Preparation of spheroplasts: One hundred ml of IJ1200(pWF185),
IJ1198(pHisFxsA) or Top10(pHisPifA) were grown at 37˚C to A600= 0.7 and
harvested by centrifugation. Cells were suspended in 10 ml of ice-cold 0.5 M
sucrose, 100 mM Tris-HCl, pH 8.0, 5 mM EDTA. After addition of lysozyme to
80 µg/ml, an equal volume of ice-cold H2O was added and the mixture was
incubated on ice for 10 min. The formation of spheroplasts was monitored by
microscopy to ensure that less than 10% of intact cells remained. After adding
MgSO4 to 20 mM, spheroplasts were collected using a microcentrifuge at 10,000
rpm for 1 min and were then resuspended in 10 ml of ice-cold 0.25 mM sucrose,
50 mM Tris-HCl, pH 8.0 10 mM MgSO4 (Cao et al., 1994).
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Preparation of inverted membrane vesicles (IMV):  One hundred ml of
IJ1200(pWF185), IJ1200(pHisfxsA) or Top10(pHisPifA) cells were grown and
harvested as described for spheroplasts. The cell pellet was suspended in 10 ml of
50 mM Tris-HCl, pH 8.0, 0.1 mM NaCl, 20 mM EDTA. Cells were disrupted by a
single passage through a French pressure cell at 16,000 p.s.i. Unbroken cells and
cell debris were removed by centrifugation at 5,000 x g for 10 min at 4˚C. This
procedure results in the conversion of at least 95% of cells into inverted membrane
vesicles (Grundling et al., 2000; Blasi et al., 1999).
Proteinase K treatment: One ml of a suspension of spheroplasts or IMV was
treated with 1mg/ml proteinase K at 37˚C for various times; digestion was stopped
by the addition of 2 mM PMSF. One sample was treated with 2% Triton X-100
before proteinase K treatment. Spheroplasts were collected by pelleting at 10,000
rpm in a microcentrifuge for 1 min and IMV were collected by centrifugation at
100,000 x g for 2 hr. Pellets were dissolved in 2 x SDS-loading buffer and boiled
for 5 min for SDS-PAGE analysis. The presence of FxsA or PifA was determined
by immunoblotting using antibody against the C-terminus of FxsA or anti-PifA
antibody.
Examination of the effect of mutation fxsA pec109 on the cell growth
Approximately 103 exponentially growing cells of each of the following
strains, IJ1199 NalR, IJ1199 fxsA::cat, IJ1198 fxsA::kan and IJ1198 T5R, were
mixed and incubated in either LB or M9 minimal glucose at 30˚C or 37˚C to a
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density of 2 x 108 cells /ml. Cultures were harvested and viable cells of each strain
were counted as colonies on LB plates after selection for antibiotic or phage T5
resistance. The purpose of using this mixed culture was to magnify any growth
defects of these strains by growing them in competition. For measuring the total
number of viable cells when cultures reach saturation, 103 cells of each strain were
grown separately under the same conditions as above until the culture was
saturated. The total number of viable cells in each culture was measured as colony
forming units after plating on LB plates. Approximately 103 exponentially growing
cells of each of the following strains, IJ1199 NalR, IJ1199 fxsA::cat, IJ1198
fxsA::kan and IJ1198 T5R, were mixed and incubated in either LB or M9 minimal
glucose at 30˚C or 37˚C to a density of 2 x 108 cells /ml. Cultures were harvested
and viable cells of each strain were counted as colonies on LB plates after
selection for antibiotic or phage T5 resistance. The purpose of using this mixed
culture was to magnify any growth defects of these strains by growing them in
competition. For measuring the total number of viable cells when cultures reach
saturation, 103 cells of each strain were grown separately under the same
conditions as above until the culture was saturated. The total number of viable
cells in each culture was measured as colony forming units after plating on LB
plates.
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  Chapter 3.  Results and Discussion
ISOLATION OF E. COLI  MUTANTS  THAT  SUPPRESS F EXCLUSION
Because co-expression of pifA and T7 gene 1.2 or gene 10 causes cell death
(Schmitt and Molineux, 1991a), an essential cellular function must be affected by
the combination of the phage and plasmid proteins. It was reasoned that mutants of
E. coli that tolerate coexpression of gene pifA and gene 10 or 1.2 would either be
altered in this target function or would express a separate activity that could protect
the cell from the lethal interaction of the host’s and parasite’s gene product. By
selecting for tolerance to coexpression of gene 10 and pifA, Wang et al. (1999a)
isolated a single E. coli mutant. This mutant contains the fxsAp109 mutation which
allows T7 to grow in the presence of F. However, disruption of fxsA by the
insertion of a Knr cassette does not abolish the toxicity of the combination of PifA
and T7 gp1.2 or t7 gp10, suggesting that FxsA is not the cellular target of the
parasites’ proteins.
A similar approach was taken to select for more E. coli mutants that
tolerate coexpression of pifA and gene 10 or pifA and gene 1.2 in the hope of
identifying the targeted cellular components. Mutants lysogenic for l 1.2pifK and
l 10pifK were isolated but no mutant was obtained that clearly supported 434-
1.2pifK growth. Nine candidate mutants were considered to have passed a patch
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Table 3. Titers of imm434 derivatives on l 1.2pifK lysogens  and l - erivatives
                                                                    Efficiency of platinga
IJ1198b(l 1.2pifK)
Lysogen                   Non-lysogen           434-1.2pifK        434-10pifK
                                      IJ1198                 2.6  ´  10-5                 3.2  ´  10-5
1                                                                    c                        1.7  ´  10-5
                                       1a                       1.7  ´  10-5            1.3  ´  10-5
2                                                                1.1  ´  10-4                  0.65
3                                                                1.5  ´  10-4            0.57
                                      3a                        1.1  ´  10-4            0.8
4                                                                1.1 ´  10-3             6.6  ´  10-4
                                      4a                         1.0  ´  10-5           5.4  ´  10-6
5                                                                1.6  ´  10-4            0.77
8                                                                1.8  ´  10-4            0.43
9                                                                3.2  ´  10-4            7.7  ´  10-4
                                      9a                         3.0  ´  10-5           1.6  ´  10-5
11                                                              3.8  ´  10-4            1.0  ´  10-3
                                     11a                        2.5  ´  10-5           1.4  ´  10-5
12                                                               2.1  ´  10-4           1.1  ´  10-3
                                     12a                        3.3  ´  10-5           1.2  ´  10-5
a  Relative to IJ1142.   b  Mutant derivative.   c  Not done.
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test using 434-1.2pifK but all grew poorly. These imm l  lysogens were then tested
quantitatively for growth of 434-1.2pifK; none was fully permissive, although one
(#4) gave plaques at a frequency of 100-fold that of the parent strain IJ1198 (Table
3).
Unfortunately, and for unknown reasons, the l 1.2-pifK prophage could not
be cured by brief thermal inactivation of the cI857 repressor from any of the
mutants. Even more surprisingly, three strains could not even be transduced by
phage P1 to imm l -sensitivity. However, no cured strain was able to support
significant growth of 434-1.2pifK and even the increased plating efficiency of 434-
1.2pifK on lysogen #4 was lost following removal of the prophage.
The lack of full sensitivity of these strains to 434-1.2pifK suggests that any
mutation(s) they contain confers tolerance only to a low level of gp1.2 and PifA.
Perhaps the increased level of 1.2 and pifA expression from the derepressed or
excised prophage l 1.2-pifK is lethal to these cells or there is a second mutation
that makes these strains dependent on the prophage which cannot, therefore, be
cured.
Unexpectedly, four l 1.2-pifK lysogens, only one of which (#3) could be
made non-lysogenic, supported the growth of 434-10pifK (Table 3). Therefore,
survivors of a challenge with pifA and T7 gene 1.2 are also tolerant to gene10 and
pifA. Non-lysogenic strain #3a was transduced with P1 grown on IJ1203
(fxsAp109::Kn). All 48 Knr transductants tested became resistant to 434-10pifK,
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suggesting that strain 3a contained a fxsA mutation. The chromosomal fxsA region
of the four l 1.2-pifK-tolerant strains that also supported growth of 434-10pifK was
then amplified and sequenced. All contained the same G® T mutation in the -10
region of the fxsA promoter. This is also the same mutation (fxsAp109), present in
IJ1199, which was however isolated for tolerance to l 1.2-pifK.
Twelve independent mutants were selected as survivors of a gene 10 and
pifA challenge. All clearly supported the growth of 434-10pifK but all were shown
to contain at least two chromosomal mutations. Removal of any one mutation by
transduction either prevented growth or allowed only very poor growth of 434-
10pifK, but also removed all easily scored phenotypes, making further analysis
problematic. In addition, these mutants could not serve as donors for transduction
of the 434-10pifK-sensitive phenotype to a naïve strain and they were therefore not
studied further.
PROTEIN LOCALIZATION IN E. COLI
1. Localization of PifA
To determine where PifA is localized in E. coli, a crude cell extract was
fractionated into cytoplasmic and membrane fractions. PifA protein was detected
using anti-PifA serum and was found exclusively in the membrane fraction (Fig.
3A). Treatment of the membrane fraction with 0.5% Sarkosyl resulted in the
complete solubilization of PifA (Fig. 3B). As Sarkosyl selectively solubilizes
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Figure 3. Localization of PifA(A, B, C) and N-terminal truncated or mutant PifA
(D) in E.coli.
 A crude cell extract of IJ512, Top10(pGX25), Top10(pGX26) or Top10(pGX31)
was separated into membrane and soluble fractions, proteins were separated by
SDS-PAGE, and PifA detected after immunoblotting using anti-PifA serum. A).
Lane lane 1: soluble proteins; 2: membrane proteins.  B). The membrane was
extracted with 0.5% Sarkosyl. Lane 1: Sarkosyl-soluble; lane 2: Sarkosyl-
insoluble. C). The membrane was treated with 1M NaCl. Lane 1: soluble proteins;
lane 2: membrane proteins. D). Lanes 1, 2: PifA-del(1-462); lanes: 3, 4: PifA-
del(1-180); lanes 5, 6: PifA K59A; lanes 1, 3, 5: soluble proteins; lanes 2, 4, 6:
membrane proteins.  Each lane contains 50µg of protein.
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Figure 4. PifA fractionates as an inner membrane protein.
IJ512 inner and outer membranes  were separated on a sucrose gradient. Fractions
were assayed for  protein content ( s )  and NAH oxidase  activity ( l ). Proteins
in gradient  fractions  were also separated by SDS-PAGE (12%).  PifA and outer
membrane protein OmpA were determined by immunoblotting using  antibodies
to PifA and OmpA.
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Figure 5.  Protease accessibility of PifA in Spheroplasts and inverted membrane
vesicles (IMV).
Spheroplasts and IMV prepared from Top10(pHispifA) were treated with or
without detergent, with Proteinase K, for various times. Each sample was
subjected to SDS-PAGE and analyzed by immunoblotting. A). His-PifA was
detected with anti-histidine-tag antibody.  B).  His-PifA was detected with anti-
PifA antibody. Lanes 1-4: spheroplast samples. Lanes 5-8: IMV samples.  C).
Spheroplast samples were transferred to one membrane, which was then cut into
half from the middle of lane 3. One half of the membrane was incubated with
anti-PifA antibody and the other half with anti-histidine-tag antibody.
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cytoplasmic membrane proteins (Filip et al., 1973), this result strongly suggests
that PifA is located in the cytoplasmic membrane. Washing the membrane with
1M NaCl did not remove PifA (Fig. 3C), indicating that it is not loosely
associated via an ionic interaction. Localization of mutant proteins was also
examined by immunoblotting of fractionated cell extracts. PifA-K59A and PifA-
del(1-180) were found only in the membrane fraction (Fig. 3D); however, PifA-
del(1-462) was detected in both the membrane (60%) and soluble fractions (40%).
These results suggest that amino acid residues between codon 181 and 463
contain sequences associating with the membrane and some incomplete
membrane localization sequences also likely exist distal to codon 462.
 Membrane proteins were further separated into inner and outer membrane
fractions through a 25-55% sucrose step gradient (Osborn et al., 1972). Two
distinct peaks of protein were found (Fig. 4); as expected, OmpA, an outer
membrane marker, was detected in the heavy fractions, whereas NADH oxidase, a
cytoplasmic membrane protein, was found in the light fractions. The presence of
PifA coincided with the inner membrane fractions, showing that PifA is associated
with the inner membrane.
 To determine whether PifA is an integral or membrane-associated protein,
a protease accessibility assay was conducted. One major band (45kDa) was
detected by anti-his-tag antibody in spheroplasts prepared from Top10(pHisPifA
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(Fig. 5A). When the same spheroplast sample was immunoblotted by anti-PifA
antibody, two major cleavage products of 45 and 50 kDa were observed although
most PifA appeared protease-resistant (Fig. 5B). In contrast to spheroplasts, no
major cleavage product of PifA was detected in inverted membrane vesicles
(IMV), indicating that the major portion of PifA is in the cytoplasm. The fainter
protease-resistance bands likely correspond to the small fraction of inner
membrane vesicles that are not inverted.
A second experiment confirmed the presence of the 45 and 50 kDa
fragments visualized by anti-PifA antibody but also showed that PifA was almost
completely degraded by incubation with proteinase K (Fig. 5C). Anti-his-tag
antibody also revealed a 45kDa fragment that migrated exactly with the fragment
visualized by anti-PifA (Fig. 5C, lane 3). These results suggest that PifA might
have a periplasmic domain(s) and the 45kDa band represents the N-terminal
portion of PifA whereas the 50kDa band is C-terminal. However, the sum of 45
kDa and 50 kDa does not correspond to the molecular weight of PifA (80kDa).
The fainter bands between 40 and 80 kDa (Fig. 5 A) and one between 50 and 80
kDa (Fig. 5 B) may result from either degradation or cross-reactions of the
antibodies and other cellular proteins. It is not clear why the full length PifA
(80kDa) was almost completely degraded in the second experiment (Fig. 5C, lanes
2 and 3) but not in the first (Fig. 5A and B). In addition, the combined intensity of
the 45 and 50 kDa bands (Fig. 5C, lane 2) is much less than that of the untreated
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PifA (80kDa) (Fig. 5C, lane 1). No strong conclusions on the membrane topology
of PifA could be made from these experiments.
An alternative approach to determine whether PifA has transmembrane
domain uses PhoA fusions. Various computer algorithms predict different, and
some even predict no, transmembrane domains for PifA and there was no obvious
region of the protein to target. A selection for TnphoA insertions into a pifA
plasmid was initially performed. More than 5000 KnR colonies were obtained, ten
were blue but none contained an insertion in pifA. Eight contained an insertion in
bla, the ampicillin resistance gene, one in cat, the chloramphenicol resistance gene
(two different plasmid constructs were used in this study), and one in pifC. These
results are surprising, a selection for antibiotic resistance had been maintained and
thus both the bla and cat insertions resulted in active gene products. Furthermore,
chloramphenicol acetyl transferase and PifC are both known to be cytoplasmic
proteins.
Four pifA-phoA fusions were constructed using convenient restriction sites
corresponding to PifA codons 121, 175, 275 and 520; an additional eight were
made using oligonucleotides to provide fusions to the putative proteinase K
cleavage region of PifA (codons 332 - 381). No fusion yielded blue colonies on
indicator plates. The failure to find blue colonies suggests either that fusions to a
periplasmic domain(s) of PifA are lethal, PifA has a very short periplasmic loop
that was not disrupted by a TnphoA insertion, or that PifA does not have a
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periplasmic domain. This last idea contradicts the results from the protease
accessibility assay. The necessity for high pifA expression for detection of PifA in
fractionated membranes by immunoblotting, and the use of multicopy plasmids for
the phoA fusion studies may have caused protein or fusion protein mis-
localization. With higher titer antibodies it may be possible to conduct the protease
accessibility assay using cells containing F as the source of pifA, and if a
transmembrane topology is confirmed there would be justification for making new
phoA fusions on single copy vectors. It is obvious that more data are needed to
determine whether PifA is an integral or merely a membrane-associated protein.
2. Localization of T7 gp10A and gp1.2
Overexpression of fxsA suppresses F exclusion and it was shown that FxsA
is an inner membrane protein (Wang et al., 1999a; 1999b). In that study, PifA was
also shown to associate with the inner membrane. It was therefore of great interest
to know where gp10 and gp1.2 are localized. To address this question, I carried out
western blot analyses of fractionated cell extracts using anti-gp10A and anti-gp1.2
serum. Gp10 is largely insoluble in buffers containing low salt (Cerritelli and
Studier, 1996a); to minimize aggregation or inclusion body formation of gp10A
due to its low solubility, gp10A was expressed from a low copy number plasmid
without induction. Gene 1.2 was expressed from a high copy number plasmid but
was induced with a low concentration (0.1mM) of IPTG. Cell extracts were
separated into cytoplasmic and membrane fractions. Both gp10A and gp1.2 were
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Figure 6.  Localization of T7 gp10A.
A cell extract of IJ1199(pQ)(pWSK10A) was separated into membrane and
soluble fractions, and proteins were resolved by SDS-PAGE. Gp10A and FxsA
were detected by immunoblotting using anti-gp10A (lanes 1 and 2) and anti-FxsA
serum (lanes 3 and 4). M: markers; lane 1, 3: soluble proteins; Lane 2, 4:
membrane proteins. 25 µg of protein was loaded onto each lane.
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Figure  7.  Localization of T7 gp1.2.
A cell extract of IJIJ1199(pQ)(pAK25) was separated into membrane and soluble
fractions, proteins were  separated by SDS-PAGE. Gp1.2 and FxsA were detected
by immunoblotting using anti-gp1.2 (lanes 1, 2) and anti-FxsA serum (lanes 3, 4).
M:  markers; Lanes 1, 3: soluble proteins; Lanes 2, 4: membrane proteins. Each
lane contains 25 µg of protein.
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detected only in the cytoplasmic fraction (Figs. 6 and 7) indicating that both
gp10A and gp1.2 are soluble proteins in E. coli. During membrane fractionation
of gp10A- and gp1.2-containing cells, FxsA was only detected in the membrane
fraction.
I also observed that 15-20% of gp10A fractionated with the membrane
when gp10A was expressed from IJ1199(pWSK10A) after IPTG induction (data
not shown). However, this small portion of gp10 was not detected with the
membranes when NaCl (0.1M) was added to the cell extract before fractionation.
Therefore, this apparent mis-localization of gp10A may be due to its insolubility or
to artificially high levels of expression.
TOPOLOGICAL AND FUNCTIONAL STUDIES OF FXSA
1. Both N- and C-termini of FxsA cytoplasmic
 Most computer algorithms predict that FxsA is an integral membrane
protein with three transmembrane domains. An initial study of PhoA fusions
suggested that FxsA has either three or four transmembrane domains, but the data
were incomplete and some were hard to explain (Wang, 1998). To determine the
proper membrane topology of FxsA, localization of its C-terminal domain was first
investigated by protease accessibility assays in both inverted membrane vesicles
and spheroplasts. In order to reduce the risk of mis-localization of FxsA due to
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Figure 8.  Both C- and N-termini of FxsA are cytoplasmic.
Spheroplasts and inverted membrane vesicle (IMV) were treated with Proteinase
K, with or without detergent, for various times. Each sample was subjected to
SDS-PAGE and analyzed by immunoblotting. A). N-terminal his-tagged FxsA
was detected with anti-his antibody.  B). FxsA was detected with anti-C-terminal
FxsA antibody. Lanes 1-4: spheroplast.   Lanes 5-8: IMV. C). OmpA is accessible
to proteinase in spheroplasts. Lane 2: no proteinase K.  Lane 3: proteinase K.
Thioredoxin in spheroplasts was resistant to proteinase K. Lane 4: no proteinase
K. Lane 5: proteinase K.
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high level expression, FxsA was expressed from a low copy plasmid. The C-
terminal domain of FxsA is susceptible to exogenous protease K in inverted
membrane vesicles but not in spheroplasts (Fig. 8). Thus the C-terminus of FxsA
is cytoplasmic. Complete digestion of OmpA by proteinase indicated a high
efficiency of spheroplast formation, whereas the complete resistance of the
cytoplasmic protein thioredoxin to external proteinase suggests that the inner
membrane was not leaky.
A similar procedure was employed to determine the orientation of the N-
terminus of FxsA. No antibody to the N-terminus of FxsA was made, in part
because it was thought that this region comprises a transmembrane domain and
would likely be insoluble. Therefore an N-terminal his-tagged FxsA was
constructed; it is fully active in vivo as judged by the plating efficiency of T7 on
IJ511/F´lac (Table 4). It is thus unlikely that the positively charged his-tag
significantly alters the orientation of the native protein. Immunoblotting results
using an anti-histidine tag antibody indicate that the his-tag at the N-terminus of
FxsA is protected from protease K digestion in spheroplasts, but not in inverted
membrane vesicles. Thus the N-terminus of FxsA is also cytoplasmic. As both
termini of FxsA face the cytoplasm, and as previous work had established that
FxsA spans the membrane there must be an even number of transmembrane
segments. However, as no FxsA fragments could be detected after proteinase K
digestion of spheroplasts any periplasmic segments must be short.
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2. Alkaline phosphatase activities of FxsA-PhoA fusions
To investigate the membrane topology of FxsA, a series of fxsA-phoA gene
fusions were constructed. Because alkaline phosphatase is only enzymatically
active in the oxidizing environment of the periplasm and is inactive when
cytoplasmic (Boyd et al., 1989a), phosphatase activities of hybrid proteins
correlate with the cellular location of the domain to which phosphatase is fused.
However, simply finding phosphatase activities with a given fusion is not
conclusive evidence that a particular domain is normally localized to the
periplasm. Fusions to cytoplasmic domains of a protein nearly always show some
activity due to a small amount of export (San Millan et al., 1989). On other hand,
low phosphatase activity does not necessarily mean that a domain is cytoplasmic
because low levels of a hybrid protein could give the same result. Thus it is
important to determine the efficiency with which various fusion proteins localize
their phosphatase portion to the periplasm. In this study, specific activities were
calculated by relating phosphatase activity to the amount of hybrid protein.
Because hybrid proteins in which the phosphatase portion is localized to the
cytoplasm are often unstable, specific activities were estimated by the rate of
synthesis of the fusion protein in a pulse-label experiment. All fusion proteins were
detected at their expected sizes and appeared to be synthesized at various rates
(Fig. 9). Most fusions gave the expected full-length product although K53 showed
low levels of degradation.
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The fusions S18, A24, L84, P88 and L95 exhibit high levels of phosphatase
(> 50 units) (Fig. 10). All fusions lie near predicted periplasmic domains of the
four transmembrane segment model. Fusions S40, S45, V47, K53, P68, S77 and
P122 show much lower activity (0.71-12.1 units) and are near predicted
cytoplasmic domains. Two fusions (T32 and P102) display intermediate activities
(18.3 and 29.2 units) and lie near the middle of predicted transmembrane
segments. Therefore the model that FxsA has four transmembrane domains is
strongly favored. The result is also in agreement with that of the protease
sensitivity assay. The intermediate activities of T32 and P102 are probably because
each is missing at least half the transmembrane segment and downstream
cytoplasmic sequences. Without positively charged residues in cytoplasmic
domains to serve as an anchor, phosphatase can be exported to the periplasm
(Boyd et al., 1987; San Millan et al., 1989).
In her initial characterization of FxsA topology, Wang (personal
communication) made three independent fusions to the residue V47. On X-P
plates, one gave dark blue, one gave pale blue and one gave white colonies. The
results of both pulse-labeling and immunoblotting experiments showed that the
fusion proteins from blue colonies were synthesized at 2.5 to 4.5 times higher rates
than the fusion from the white colony but all specific activities were comparable.
Thus, blue colonies and the resulting confusion about FxsA topology was due to
increased synthesis of fusion proteins in some constructs. Notably, five fusions to
71
 P68     S77    L84    P88    L95    P102   P122  
 S18     A24    T32     S40    S45     V47     K53
Figure 9.   Immunoprecipitated pulse-labeled FxsAphoA fusion proteins.
FxsA-phoA hybrid proteins were precipitated with anti-alkaline phosphatase
antibody after a 1-min pulse-label with [  35S ]  methionine and resolved on a SDS-
PAGE gel and visualized by phosphorimagery.
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Figure 10. Alkaline phosphatase activities of fxsA-phoA fusions and a proposed
membrane topology of FxsA.
 A). Alkaline phosphatase activity of each fxsA-phoA fusion is shown with an
arrow pointing to the site at which the fusion joint is located. All assays used the
strain CC118 containing a fxsA-phoA plasmid. The specific activities were
determined by dividing alkaline phosphatase activity by intensity of each band.
The intensity of the T32 band was arbitrarily set at 1, and other bands were
normalized to that value. B). Predicted FxsA sequence.
B
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the same cytoplasmic loop of FxsA show significant differences in activities. The
activities of fusions S40, S45, V47 are several-fold higher than those of K53 and
P68. A possible explanation is that three positive charged residues (R48, K53 and
K61) in the middle of the cytoplasmic loop may be crucial to anchor the second
transmembrane stretch in the right orientation. Without these residues, a portion of
phosphatase could be exported to the periplasm and provide activity. As the rate of
synthesis of certain fusion proteins (e.g. V47) increases, more phosphatase is
localized in the periplasm, resulting in an increased activity. A similar observation
and explanation was reported for Mal F-phoA fusions (Boyd et al., 1987). Fusions
of phosphatase to the beginning of a cytoplasmic domain of MalF (i.e., no
cytoplasmic residues were included in the fusion) showed 7- to 20-fold higher
activity than fusions to the end of the same cytoplasmic domain.
3. Membrane domains of FxsA are essential for alleviating F exclusion
 Most computer algorithms predict that FxsA has three transmembrane
domains. By using 19 residues as the length of a transmembrane segment some
algorithms will predict four transmembrane domains and provide a structure that is
in a good agreement with the results of the protease sensitivity assay and with the
phoA fusion study. According to this model structure, the fourth transmembrane
domain spans from glycine 96 to proline 114. To investigate the importance of the
membrane domains of FxsA in protecting T7 from F exclusion and to determine
the precise position of the last transmembrane domain, FxsA truncation mutants
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Table 4. Relative plating efficiencies of T7 on strains containing plasmids
synthesizing N-terminal fragments of FxsA.
                              Number of amino                 Relative plating efficiencya
                              acids remaining in                          IJ511/F’lac
Plasmids                N-terminal FxsA                                 IJ511
                                                                              30 °  C                37 °  C
pHisFxsA121              121                                    0.22                   0.21
pHisFxsA115              115                                    0.4                     0.66
pHisFxsA111              111                                    0.2                     0.28
pHisFxsA107              107                                    0.04b                  0.27b
pHisFxsA102              102                                   < 10-7                 < 10-7
pHisFxsA                    158(wild type)                  0.37                   0.26
pTrchisA                     N/Ac                                  < 10-7                        < 10-7
a. Cells were grown to stationary phase in LB without IPTG induction.
b. Pinpoint plaques.
c. Vector plasmid.
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lacking various parts of the normal C-terminus were created. The ability of the
mutant proteins to suppress F exclusion was then examined. A FxsA truncation
containing the N-terminal 111 of the normal 158 residues still allows T7 to plate
normally in male cells (Table 4). FxsA containing only 107 residues also permits
T7 to grow in male cells with essentially the same plating efficiency at 37˚C,
although at 30˚C the plating efficiency decreases about 7-fold. Plaques on the
FxsA107 host are also very small indicating that the mutant protein has partially
lost activity. The FxsA truncation containing 107 residues is missing about one-
third of the predicted fourth transmembrane domain, which is likely the cause for
the partial loss of function. A deletion of 5 additional amino acids, providing a 102
residue FxsA, fails to support T7 to grow in male cells. The stability of each
truncated FxsA (FxsA102, 107 and 111) was examined by immunoblotting using
anti-his-tag antibody and were found to be stable (data not shown), indicating that
the defect in their function is not due to an inability to accumulate in the
membrane. Because a truncated FxsA containing 111 amino acids is fully
functional, the last transmembrane domain likely terminates between histidine 107
and lysine 111. The latter may be important in anchoring the mutant protein in the
membrane.
The results of this deletion study fit a four transmembrane segment model
of FxsA better than a three segment structure. More importantly these data strongly
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suggest that the membrane is the site where F exclusion of T7 occurs. Truncations
removing the entire cytoplasmic C-terminal tail of FxsA remain fully active in
alleviating F exclusion of T7. It can therefore be concluded that either the
cytoplasmic loop between serine 45 and alanine 69 or the cytoplasmic membrane
itself is the site where F exclusion of T7 development occurs. It would be
interesting to mutate residues within the cytoplasmic domain and to determine the
effects on the protective activity of FxsA. Alternatively, or perhaps in addition,
transmembrane segment swaps with other known membrane proteins might prove
highly informative.
4. The effect of fxsAp109 mutation on cell growth
A promoter-up mutation in E. coli fxsA causes a 25-fold increase in
expression of fxsA RNA (Wang et al., 1999a). It has been shown that fxsA is not
essential for cell viability because fxsA insertions do not inhibit cell growth, but it
is not known whether the presence or absence of fxsA affects the growth rate.
Strains carrying various fxsA alleles were therefore grown in competition in the
same culture under different conditions (Table 5).
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Table 5.  The effect of fxsA allele on cell generation time.
__________________________________________________________________
                                                                                  Generation time (min)
                                                        ______________________________________
                    Relevant genotypea                 30 °  C                              37 °  C
                                                        __________________     __________________
                                                           M9                LB             M9                LB
__________________________________________________________________
IJ1821     fxsApec109  fxsA+ NalR     82.2               43.6           70.4              33.5
IJ1820      fxsAp+ fxsA+  T5R             74.6               37.3           58.1              24.5
IJ1024     fxsAp+ fxsA::kan               73.4               38.7            58.5              23.7
IJ1291    fxsAp109 fxsA::cat             74.4              36.7            57.9              23.4
__________________________________________________________________
a.  All strains are derivatives of IJ1198.
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Overexpression of fxsA in the strain IJ1821 causes a slower rate of growth
in both rich and minimal medium, and at both 30˚C and at 37˚C. The generation
times of IJ1821 are 6 and 7.6 min, respectively, longer than those of IJ1820 in LB
and M9 minimal medium at 30˚C. At 37˚C, these differences increase to 8.9 and
12.3 min. IJ1199 grows at 43˚C; growth rate measurements were not performed at
this temperature but it is expected that the differences in growth rate would be
even greater. In contrast, a fxsA null mutation in either the IJ1198 or IJ1199
background does not manifest an overt detrimental effect on cell growth.
The number of viable cells of IJ1821 in saturated cultures was also
compared with the isogenic fxsA+ and fxsA::Kn strains IJ1820 and IJ1204. No
significant difference was observed. Therefore, the fxsAp109 mutation in IJ1199
retards the rate of cell growth, but allows cells to reach normal cell densities at
saturation.
BIOCHEMICAL STUDIES
1. Protein purification
His-tagged proteins: As judged by staining with Coomassie Brilliant Blue, all his-
tagged proteins were purified to near homogeneity by metal-chelate affinity
chromatography (Fig. 11). The tagged proteins are all active in vivo as judged by
phage plating or transformation assays (Tables 6, 7 and 8). Both his-gp1.2 and his-
PifA are soluble in the buffer used. His-10A was soluble only at low
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Figure 11. Protein purification.
Purified proteins were separated on A) and B) 12%  (PifA, gp10A and FxsA) or
C) and D)15% SDS-PAGE gels (gp1.2) and stained with Coomassie Brilliant
Blue.
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Table 6. Plasmids expressing 1.2 or 10A fusion proteins are toxic to strains
containing F
Plasmid           genotype of T7 DNA a                  Transformation efficiency b
                                                                                            ( F’lac/  F-)
 pAK25                   1.2+                                              0.0019
 pGX107c                his-1.2+                                                           0.001
 pGST1.2                gst-1.2+                                           0.016
 pAR1338               10 A+                                             2.5 ´ 10- 4
 pHis-10A               his-10 A+                                      1.05 ´ 10- 4
 pTrchisA                                                                    1
 pKE11h                                                                        1
 pGEX-3X                                                                    1
 pUC 18                                                                       1
 pBR322                                                                      1
__________________________________________________________________
      
a.  Gene 1.2 is expressed from the T7 10 promoter in pGX107, tac in pGST1.2
and lac in pAK25. Gene 10is transcribed from trc in pHis-10A, T7 10 promoter
in pAR1338. Transformations were done under conditions in which the promoters
were induced except for T7 10 promoter in pAR1338.
b.  Transformation efficiencies are calculated as the ratio of the number of
transformant colonies obtained on IJ511/F’lac to those obtained on IJ511/F-,
normalized by the relative transformation efficiencies of the parent vector
plasmids in each strain.
c. T7 RNA polymerase was supplied from the compatible plasmid pPK41.
IJ511/F’lac(pPK41) and IJ511(pPK41) were used as male and female strains
respectively.
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Table 7.  Complementation by plasmids expressing his-tagged mutant 1.2
proteins
                  Plasmids        Genotype of T7 DNA           EOP of T7 on IJ511(pPK41)/F’lac
                                                                      Containing a his-tagged mutant gene
                                                                      1.2 plasmid a
  pGX105                1.2 Y28N                                              0.6
  pGX106                1.2 W31C                                             1.03
  pGX109                1.2 R37G                                              0.86
  pKE11Hb                                                                           < 10-7
a EOP (Efficiency of Plating ) is relative to the  female strain IJ511(pPK41).
pPK41 supplies T7 RNA polymerase gene.
b. Parent vector plasmid.
  Table 8. Plating efficiency of T7 on IJ511(pHisPifA)
  Plasmids                         Genotype                              Plating efficiency a
  pHisPifA                         pifA+                                            < 10-6
a  Relative to IJ511(pTrchisA), pTrchisA is parent plasmid vector. Expression of
pifA is under trc promoter control, cells  were  grown  without induction.
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Table 9.  Concentrations of gp1.2, gp10A and PifA in E. col
____________________________________________________
                                       IJ511                     IJ511/F’lac
_____________________________________________________
                                          µM                           µM
  gp1.2                               1.5                              0.7
  gp10A                             49.5                            2.1
  PifA                                                                   8.3
_____________________________________________________
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concentrations.
T7 gp10A: The T7 capsid protein 10A is largely insoluble when concentrated cell
extracts are made, but is mostly soluble if cells are lysed at a concentration of 1010
cells/ml in 20 mM Tris-HCl, pH 8.0, 3 mM b -mercaptoethanol, 10% glycerol, 2
mM EDTA, 100 mM NaCl, 0.1% Triton X-100 (Cerritelli and Studier, 1996a).
Taking advantage of its low solubility, 20% ammonium sulfate could be used to
precipitate gp10A, a concentration where most cellular proteins are still soluble.
The solubilized ammonium sulfate pellet containing gp10A was then purified to
homogeneity by DEAE ion exchange chromatography; gp10A flows through the
resin to which most cellular proteins bind (Fig. 11A). Purified gp10A can only be
kept soluble at ³ 0.3 mg/ml in 20 mM Tris-HCl, pH 8.0, 3 mM b -mercaptoethanol,
10% glycerol, 2 mM EDTA, 100 mM NaCl. No reagent or condition has been
found to increase significantly the solubility of gp10A.
T7 gp1.2: After induction with IPTG gp1.2 becomes a major fraction of the total
cell protein. Purified gp1.2 was nearly homogeneous as judged by SDS-PAGE
after staining with Coomassie Brilliant Blue (Fig. 11C and 11D).   
2. Quantitation of gp1.2, gp10A and PifA in E. coli
PifA, gp1.2 and gp10 are the three proteins known to be responsible for F
exclusion of T7. Previous data suggested that the concentrations of these proteins
in each infected cell are directly related to the severity of exclusion. To gain more
understanding of the mechanism of F exclusion, the amounts of gp1.2 and gp10A
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in infected cells and the amount of PifA produced from the F plasmid were
measured by quantitative immunoblotting. For quantification of gp1.2 and gp10A,
cells were infected with T7 and harvested before cell lysis. IJ511/F’lac was used to
measure PifA concentrations. Cell extracts were immunoblotted and quantified
using the corresponding purified proteins as standards. Although rates of synthesis
of T7 proteins are not known to be affected by the multiplicity of infection, in
order to avoid possible complications of gene dosage resulting from varying
numbers of phage genomes in cells, gp10 levels were measured in cells infected at
an m.o.i. of 0.4. This multiplicity gives the maximum percentage (33%) of cells
being infected and where almost every infected cell receives only one phage.
Unfortunately, at this m.o.i. the quantity of gp1.2 produced in F+ cells was too low
to be measured accurately. Thus, gp1.2 in both F- and F+ cells was measured at an
m.o.i. of 5.
T7 gp1.2, an early protein, is synthesized at relatively low levels as judged
by protein accumulation in an F- strain (Table 9). About 1500 copies of gp1.2 per
cell corresponds to 1.5 µM. In F+ cells, where exclusion of T7 inhibits late protein
synthesis in particular, the concentration of gp1.2 is decreased about 50%. Because
gene 1.2 is transcribed both early and late during infection and as gp1.2 itself
causes exclusion, some inhibition of protein synthesis is not unexpected. The
reduction in gp1.2 accumulation is comparable to that found in earlier studies.
Morrison et al. (1974) observed in F+ strains that the early protein gp1 was
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synthesized at 75% the rate of F- strains. Britton and Haselkorn (1975) and
Whitaker et al. (1975) reported that gp1 and gp1.3 synthesis in F+ strains was 40-
60% and 30-40%, respectively, that of an F- strain. However, T7 RNA polymerase
(gp1) is only made early after infection and its synthesis would not be expected to
be severely inhibited. Gp1.3 is made both early and late, like gp1.2, but these early
studies measured its rate of protein synthesis by pulse-labeling with
[35S]methionine. Uptake of amino acids is affected during F exclusion of T7
(Schmitt et al., 1991) and thus incorporation of radioactive amino acids cannot be
used in a quantitative manner.
As expected for a major capsid protein, gp10A is extremely abundant in an
F- strain (Table 9). As each virion contains 415 copies of gp10, 49.5µM gp10A is
sufficient to yield 150 progeny phages per cell. This value is within the range of
the T7 burst (100–200) in permissive hosts, thereby confirming that the
immunoblotting procedures employed are accurate. In contrast to gp1.2, the
amount of gp10A synthesized in male cells is reduced by 95%. A concentration of
2.1 µM would allow a burst of 6 phage particles/cell, which is comparable to that
found in a closely related F+ strain by Spence et al., (1983). Morrison et al. (1974)
reported that no gp10 was detected in F+ strains, but Condit and Steitz (1975)
showed that the total amount of gp10A in F- cells was 48-63% of F+ cells. The
result from this work is different from both earlier studies. The differences may be
ascribed to the techniques employed here; Morrison et al. pulse-labeled proteins in
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the interval of 13-15 min after infection and recovered by immunoprecipitation
using anti-T7 antibody, whereas Condit and Steitz compared levels of pulse-
labeled proteins from 6-10 min after infection. In this study the amount of gp10A
was measured as the total accumulation during 20 min of infection. In addition, the
F plasmid inhibits T7 to different levels when present in different host
backgrounds and the use of different E. coli strains by the various researchers may
also lead to differences in the degree of inhibition of late protein synthesis.
3. Protein interactions
1). PifA interacts with gp10A, gp1.2 and FxsA
 a). Genetic studies showed that in the absence of phage infection, the
combination of either gp10A or gp1.2 and PifA causes cell death (Schmitt and
Molineux, 1991). It was therefore reasoned that PifA interacts both with gp10A
and with gp1.2, and that each interaction initiates a chain of reactions leading to
death of the phage-infected cell. Clearly a host function is attacked by the
combination of PifA and either gp10 or gp1.2 during the abortive infection.
However, this host target has not yet been identified. Overexpression of FxsA
protects T7 from F exclusion but FxsA is known not to be the cellular component
targeted by PifA and a T7 protein. Although the specific mechanism of this
process remains unknown, several hypotheses can be advanced. T7 gp10 or gp1.2
may interact directly with PifA, the combination then interacts with the cellular
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Figure 12. PifA interacts with T7 gp1.2, gp10A and FxsA.
His-PifA resin was incubated with gp1.2 (A), gp10A (B) and FxsA (C) cell
extract.  The eluatewas analyzed by immunoblotting using anti-gp1.2, anti-gp10A
or anti-FxsA serum.
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target; a T7 protein (gp10 or gp1.2) may interact with the cellular target, which
then interacts with PifA; or vice versa, PifA may initially interact with the cellular
target. In addition, gp10 or gp1.2 and PifA may each interact separately with the
cellular target. The potential functions of FxsA in alleviating exclusion are equally
variable. For example, FxsA may interact with PifA and/or the cellular target to
prevent them from interacting with gp10 and gp1.2.
To investigate whether PifA physically interacts with gp10A, gp1.2 or
FxsA and to try and identify the cellular component targeted by these proteins, a
PifA affinity resin was prepared. Cell extracts containing gp10A, gp1.2 or FxsA
were then incubated with the resin as described in Materials and Methods. After
removal of unbound material, all specifically bound proteins were eluted. A
comparable resin containing SP6 RNAP as the affinity ligand was used as a
negative control. Gp10A, gp1.2 and FxsA were found to bind PifA (Fig. 12),
indicating that all three interact specifically with PifA. To determine whether these
interactions occur independently of any E. coli molecule, purified gp10A and
gp1.2 were chromatographed on the PifA resin. Gp10A and gp1.2 bind to PifA in
the absence of any E. coli component, suggesting that both gp10A and gp1.2 can
bind directly to PifA. Other than FxsA no E. coli protein was found that bound
PifA, and even this interaction could not be detected without overexpression of
fxsA. (data not shown). This last observation implies that any interaction between
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PifA and its cellular target is weak, that the target is not a soluble component of the
cell, or that its concentration is below detection levels.  
To determine the strength of the interaction with PifA and gp10A, and with
PifA and gp1.2, a step gradient of NaCl was used to elute proteins from the PifA
resin. Gp1.2 eluted at 250 mM NaCl (Fig. 13), whereas gp10A eluted between
300-350 mM NaCl (Fig. 14). Using a comparable resin bound with SP6 RNAP
both gp1.2 and gp10A eluted with the washing buffer (25mM NaCl). Thus both
gp1.2 and gp10A interact specifically with PifA, but gp10A binds with a higher
affinity. The strength of the interaction between PifA and gp1.2 or gp10A
correlates well with the toxicity of the phage proteins in male cells. Transformation
efficiencies suggested that gp10A is more detrimental than gp1.2 to cells
containing F (Schmitt et al., 1991). The present study confirms that observation
and also shows that a complex of PifA and gp10A or of PifA and gp1.2 can be
disrupted by high ionic strength, indicating that the protein-protein complex is
maintained by ionic interactions.
The binding affinity of FxsA for PifA was also estimated by measuring the
concentration of NaCl required to elute FxsA from PifA resin. Because no purified
FxsA was obtained (due to the toxicity of fxsA overexpression) a cell extract was
used to provide FxsA. The protein was eluted with 150mM NaCl (Table 10); the
salt sensitivity of FxsA binding to PifA indicates that these proteins also interact
through ionic bonds.
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Figure 13.   Elution of gp1.2 from a PifA resin.
Mutant and wild type gp1.2 were incubated with his-PifA bound to Affi-Gel 10
resin and eluted with a step gradient of NaCl. : gp1.2 Y28N; : gp1.2 W31C; :
gp1.2 R37G; s: wild type gp1.2; l: SP6 his-RNAP.
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Figure 14.   Elution of gp10A from a PifA resin.
Mutant and wild type gp10A were incubated with his-PifA bound to Ni-NTA
agarose and eluted with a step gradient of NaCl. l: gp10A A2D A228G;   :
gp10A A2D F291S; s: wild type gp10A; O : SP6 his-RNAP.
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Table 10.  The binding affinity of FxsA to his-PifA, his-10A and his-1.2
_______________________________________________________________
 His tagged                               Concentration of NaCl required
 proteins                                    to elute FxsAa
________________________________________________________________
 His-PifA                                            150 mM
 His-10A                                             100 mM
 His-1.2                                               100 mM
_________________________________________________________________
a  His tagged proteins were bound to the Ni-NTA affinity resin and incubated
with cell extract containing FxsA. The resin was eluted with buffer containing
NaCl. FxsA was detected by immunoblotting.
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Figure 15.  Titration of gp10A with his-PifA.
Various concentrations of his-PifA were incubated with 50nM gp10A. The
amount of gp10A bound was determined by immunoblotting.
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Figure 16. Titration of gp1.2 with his-Pif A
Varying concentrations of his-PifA were incubated with 100nM gp1.2. The
amount  of gp1.2 bound was determined by  immunoblotting (see Materials and
Methods for details).
0%
20%
40%
60%
80%
100%
0 0.5 1 1.5 2 2.5 3 3.5 4 4.5
%
 g
p1
.2
 b
ou
nd
His-PifA (µM)
95
 The binding affinity of his-PifA to gp10A or gp1.2 was examined further by
measuring equilibrium dissociation constants (Kd). To determine each Kd, gp10A
or gp1.2 was pre-incubated with increasing concentrations of his-PifA as
described in Materials and Methods. Complexes and unbound his-PifA were
recovered using Ni-NTA agarose beads. The resin was then washed and proteins
were eluted with 250 mM imidazole. Eluted proteins were electrophoresed on a
SDS-PAGE gel, electrotransferred to a PVDF membrane and probed using anti-
gp10A or anti-gp1.2 antibody. The titration curves were obtained after the
quantification of each protein band (Figs. 15 and 16). Kd is determined as the
concentration of his-PifA at which 50% of gp1.2 (or gp10A) bound. Apparent Kd
values were 0.3 µM for his-PifA and gp10A and 1 µM for his-PifA and gp1.2.
These values confirm the conclusion made earlier: that gp10A binds to PifA with
a higher affinity than gp1.2. Complex formation would seem to be physiologically
significant as the concentrations of PifA (8.3 µM) and gp10A (2.1 µM) in each
female cell are greater than the Kd value for their interaction and the
concentration of gp1.2 (0.7 µM) is only slightly less than the Kd value for its
interaction with PifA.
b). Gene 10 mutations reduce the interaction with PifA. All T7 mutants that escape
F exclusion contain at least two missense mutations in gene 10. A T7 gene 1.2
deletion mutant carrying these gene 10 mutations plaques on a male strain at
relatively normal efficiencies (Molineux et al., 1989). Three suggestions were
made to explain this observation. The mutations reduced the rate of capsid protein
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Figure 17.  Mutant gp10A interacts with PifA.
Cell extracts containing mutant gp10A were incubated with his-PifA (lanes 1, 3)
or SP6 his-RNAP (lanes 2, 4) and the eluates were immunoblotted.
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synthesis, perhaps also making the time after infection at which the capsid protein
reaches a critical concentration later, and the nature of interaction between capsid
protein gp10 and PifA was altered.
To address these ideas more directly, the expression levels of two mutant
capsid proteins, gp10A-A2D,A228G and gp10A-A2D,F291S were compared with
that of the wild type at both 30˚C and 37˚C by immunoblotting (data not shown).
Relative to wild-type gene 10 expression from the plasmid pET10A, mutant gene
10 expression from the equivalent plasmids pET10PC (10A-A2D,A228G) and
pET10JT (10A-A2D,F291S) were reduced by 45% and 50% respectively at 30˚C.
At 37˚C pET10PC and pET10JT expressed the mutant 10A at only 65% and 53%
the rate of wild-type.
Gold et al. (1981) reported that the presence of GCU (alanine) as the
second codon correlates with highly efficient translation. The eight most actively
synthesized T7 proteins have GCU as their second codon (Dunn and Studier,
1983). Thus the change of alanine to aspartic acid at codon 2 present in both gene
10 mutants is likely the cause of the reduced gene expression.
To examine whether the gene 10 mutations also affect the strength of the
interaction of capsid protein with PifA, batch affinity chromatography was
performed using immobilized his-PifA and extracts of cells containing gp10A-
A2D,A228G or gp10A-A2D,F291S. Both mutant capsid proteins bound to PifA
(Fig. 17). Binding strengths were assessed by measuring the concentration of NaCl
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necessary for elution. Both mutant proteins eluted at 150-200mM NaCl (Fig. 14), a
significantly lower concentration than required for wild type gp10A. This result
suggests that both mutant capsid proteins interact with PifA with diminished
affinity. Although a contribution from the codon 2 change cannot be excluded, the
elution profiles of the two mutant proteins are different, suggesting that the
reduced binding is due to the second gene 10 missense mutation.
The gene 10 mutations necessary for T7 to avoid F exclusion therefore not
only lower the expression level of gp10 but also reduce binding to PifA, and the
hypothesized reduced toxicity of the mutant gp10A is likely the result of both.
However, plasmids containing these mutant gene 10 alleles remain as incompatible
with F as wild type gene 10 in a transformation assay (Schmitt, 1991). Presumably
this assay is more sensitive to toxic proteins than is phage growth.
c). Gene 1.2 mutations reduce binding of gp1.2 to PifA. In addition to gene
10 mutations, T7 must contain a missense or null mutation in gene 1.2 to escape F
exclusion. It has been shown that plasmids containing the mutant gene 1.2
transform a male strain at essentially the same efficiency as the isogenic female
strain (Schmitt and Molineux, 1991). It was concluded that the gene 1.2 mutation
diminishes or abolishes the toxicity of gp1.2 towards pifA+ cells. To show directly
that reduced toxicity is due to a reduced affinity of the mutant gp1.2 for PifA, three
mutant 1.2 proteins, gp1.2Y28N, gp1.2W31C and gp1.2R37G, were examined for
binding to PifA. Cell extracts containing each mutant gp1.2 were incubated with
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Figure 18.   Mutant gp1.2 interactions with PifA.
Cell extracts containing mutant gp1.2 were incubated with his-PifA (lanes 1, 3, 5)
or SP6 his-RNAP (lanes 2, 4, 6) resin. The eluates were subjected to SDS-PAGE
and immunoblotted.
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Figure 19.  Interactions of mutant or N-terminal truncated PifA with gp1.2 (A)
and gp10A(B).
His-PifA resin was incubated with purified gp1.2 or gp10A and the eluate was
analyzed by immunoblotting using anti-gp1.2 or anti-gp10A serum.
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Figure 20.  Interaction of PifA with FxsA.
A). PifA resins were incubated with FxsA-containing cell extracts. Eluate from
each resin  was subjected to SDS-PAGE and analyzed by immunoblotting. Lanes
1 and 2 are duplicate of Fig 10C.
B). PifA or PifA-del(1-462) was incubated with [ 35S]  labeled his-FxsA truncation
containing its N-terminal 111 residues (FxsA111)  and precipitated with anti-PifA
antibody. Lane 1: immunoprecipitaed FxsA111 with anti-his-tag antibody.
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immobilized his-PifA. After washing, bound proteins were eluted and subjected to
immunoblotting (Fig. 18). To determine binding strengths, his-tagged mutant
gp1.2Y28N eluted from the resin at 50-100mM NaCl, gp1.2R37G eluted at 150
mM whereas wild-type gp1.2 required 250mM NaCl for elution (Fig. 13). These
data definitively show that the gene 1.2 mutations reduce the affinity of the protein
for PifA. The very weak interaction between mutant gp1.2 and PifA is probably
the major reason why the mutant gene 1.2 plasmids are compatible with PifA.
d). Mutant PifA K59A interacts with gp1.2, gp10A and FxsA. Analysis of
the predicted amino acid sequence of PifA reveals a P-loop, characteristic of an
ATP/GTP-binding motif (Saraste et al, 1990). A site-specific mutation (K59A) in
this P-loop abolishes the exclusion activity of PifA (Wang et al., 1999a). To
determine whether PifA binds ATP or GTP, a nitrocellulose membrane binding
assay was performed by incubating his-PifA with [a-32P]ATP or [a-32P]GTP at 0˚C
or at 23˚C in the presence or absence of MgCl2 for 1 hr. No binding was detected.
PifA was also mixed with [a-32P]ATP or [a-32P]GTP at 0˚C and cross-linking was
attempt using UV irradiation; again no ATP/GTP binding. However, a control
assay using T4 DNA ligase revealed ATP binding in both experiments. Either PifA
does not bind ATP/GTP or binding is extremely weak and a more sensitive assay
is necessary. For example, 5-azido-ATP could be used. Because PifA-K59A
remains membrane associated (Fig. 3D) the inactivation of PifA by the K59A
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mutation may be that interactions between PifA and one or more of gp1.2, gp10,
FxsA, or the unknown cellular target are affected.
To test whether PifA-K59A binds to gp1.2, gp10 or FxsA, immobilized
hisPifA-K59A was used as an affinity ligand. Immunoblotting showed that PifA-
K59A still binds (Figs. 19 and 20A), showing that the putative ATP/GTP binding
site is not essential for the interaction of PifA with gp1.2, gp10A and FxsA. A
domain of PifA that includes K59 could be still essential for an activity of PifA
required to change or inactivate a cellular function or a conformational change
caused by the K59 mutation could prevent PifA from interacting with the cellular
target.
 e). Gp10 binds to a different region of PifA than gp1.2 and FxsA. In an
attempt to localize the regions of PifA that directly interact with gp10A, gp1.2 and
FxsA, two his-tagged N-terminal truncation mutants of PifA were created. PifA-
del(1-462) contains the C-terminal 255 amino acids and PifA-del(1-180) contains
the C-terminal 537 amino acids. Each truncated protein was bound to Ni-NTA
agarose and tested for binding gp10A, gp1.2 and FxsA. Gp10A failed to bind
PifA-del(1-462) but still interacted with PifA-del(1-180) (Fig. 19). In contrast,
both gp1.2 and FxsA bound to PifA-del(1-462) (Fig. 19 and 20A). Thus, gp10A
interacts with PifA between residues 181 and 462, and both gp1.2 and FxsA
interact with residues between 463 and 717 (Fig 20). [Paragraphs must have more
than one sentence] Unfortunately constructs containing C-terminal deletions of
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PifA are extremely toxic to E. coli and the N-terminal region of Pif could not be
tested this way.
 The interaction of PifA-del(1-462) with a truncated FxsA containing the
N-terminal 111 residues was also examined by co-immunoprecipitation. Truncated
FxsA still binds to PifA-del(1-462) (Fig. 20B). This fragment of FxsA contains all
transmembrane domains and the small cytoplasmic loop (Fig. 10) and also
suppresses F exclusion. Binding of PifA, through its C-terminal 255 residues, to
the N-terminal 111 residues of FxsA must play a critical role in suppressing F
exclusion. The regions of PifA that have been shown to bind gp1.2, gp10 and FxsA
are summarized in Figure 21.
2). Other proteins that interact with T7 gp1.2 and gp10
a). Gp1.2 interacts with E. coli PNPase. In the hope that the cellular component
targeted by gp1.2 and gp10A during F exclusion could be identified, cell extracts
were incubated separately with immobilized his-1.2, GST-1.2 or his-10A. Proteins
bound to gp1.2 or gp10A were analyzed by SDS-PAGE. No E. coli proteins were
found to bind specifically to gp10A. As expected, a 60 kDa protein bound to
gp1.2; this protein is likely to be E. coli dGTPase. Gp1.2 is known to bind and
inhibit E. coli dGTPase (Huber et al., 1988).
Interestingly ,another E. coli protein was found to bind gp1.2 that was  identified
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PifA         N (1)                                                                                               C (717)
PifA–del (1-180)                 N (181)                                                               C (717)
PifA–del (1-462)                                                        N (463)                        C (717)
                                    PifA               PifA-del(1-180)               PifA-del(1-462)
            Gp1.2                 +                              nd                                     +
            Gp10A                +                              +                                       -
             FxsA                  +                              nd                                     +
Figure 21.  Summary of the region of PifA  interacting  with gp1.2, gp10A and
FxsA.
+: positive interaction; -: no interaction; nd: not done.
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Figure 22. T7 gp1.2 interacts with E.coli  polynucleotide phosphorylase (PNPase)
Cell extracts were incubated with either GST-1.2 bound to glutathione sepharose
or his-1.2 immobilized to NTA-Ni agarose. All proteins that were tightly bound to
the resin were eluted with either 10mM glutathione or 250 mM imidazole. Eluted
proteins were subjected to SDS-PAGE and then visualized with Coomassie
Brilliant blue. Lane 1: GST-1.2. Lane 2: his-1.2.
97 -
68 -
43 -
28 -
18 -
12 -
PNPase
dGTPase
GST-1.2
His-1.2
 1       2 
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by N-terminal  sequence analysis as polynucleotide phosphorylase (PNPase)(Fig.
22). This result suggests that gp1.2 may affect enzyme activity. Other bands
observed are likely to be proteins non-specifically bound to the resin or
degradation products of GST-12 in particular. In this binding assay no FxsA was
detected, probably because of the low binding affinity of gp1.2 for FxsA and the
small quantity of FxsA present in the cell.
To test if gp1.2 affects enzyme activity, gp1.2 and pure PNPase were
incubated at both a 1:1 and 5:1 molar ratio at 4˚, 23˚, 30˚ and 37˚C for both 1 and 4
hr, and then assayed for the polymerization and phosphorolysis activities of
PNPase using [3H]ADP or 3H-poly A, respectively, under optimal conditions for
the enzyme. Surprisingly, gp1.2 neither inhibits nor enhances these activities of
PNPase. any significance of the interaction between the two proteins is therefore
unclear.
Disruption of pnp by Tn5 increases the plating efficiency of T7 on male
cells by at least 6 orders of magnitude at 25˚, 30˚ and 37˚C (Table 11). Generally,
the phage only forms pinpoint plaques although at 25˚C and 30˚C plaques are
slightly larger. At lower temperatures male cells lacking PNPase appear to be more
permissive for T7. Conversely, pnp overexpression had no apparent effect. To
investigate whether pnp null mutations affect PifA synthesis, levels of PifA
produced from F and from a multicopy plasmid, in both pnp+ and pnp null cells,
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Table 11. Efficiencies of plating (EOP) of T7 on strains with altered PNPase
activity.
                                                        EOP (relative to the isogenic F- strain IJ511)
Strains                                       25 ° C            30 ° C                37 ° C                43 ° C
IJ511/F’lac                               <  10-7            <  10-7                 <  10-7                  <  10-7
IJ511 pnp::Tn5                            1.09             0.75                   0.72                   0.66
IJ511 pnp::Tn5/F’laca                 0.015           0.06                   0.014                0.006
IJ511//F’lac(pTrcPNP)b                                    <  10-7                  <  10-7      
__________________________________________________________________
a,   Allowed pinpoint plaques only.
b.   pTrcPNP expressing his-PNPase under trc promoter control. Cells were grown
in LB to middle log phase and induced with 0.5 mM IPTG for 2 hours before
plating.
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Table 12. Efficiencies of plating (EOP) of T7 mutants on p p null strains.
__________________________________________________________________
                                                                                       EOPa
                             ____________________________________________________
                             ST16                    MM10                                  MM20
Strains            ( D 1.2 10+  )   (1.2+ 10A2D,10A228G)    (1.2 W31C10A2D,10A228G)
____________________________________________________________________________________________________
IJ511/F’lac                             <  10-7                   1.8 x 10-5                                    0.4
IJ511 pnp::Tn5                       0.9                       0.6                                             1.7
IJ511 pnp::Tn5/F’laca            0.02                     0.05                                           0.07
a. Relative to the isogenic F- strain IJ511 at 30 ° C.
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were examined by immunoblotting. No major change in the level of PifA was
detected (data not shown). T7 was also plated on a pnp null strain to determine if
growth in male cells still required gene 1.2 and gene10 mutations. No difference
was found (Table 12), indicating that the improved plating efficiency in the
presence of F is not simply due to a reduced level of PifA, gp1.2 or gp10A. The
mechanism of partial suppression of F exclusion by the pnp null mutation appears
different from that by strA, gyrA43 and himA mutations, which simply reduce PifA
levels, but how suppression occurs is unclear. PNPase does not appear to be a
cellular target for PifA and PNPase may not be directly involved in F exclusion.
As T7 RNAs are stable throughout infection, it is possible that one normal function
of gp1.2 is to alter the activity of the E. coli degradosome (Grunberg-Manago,
1999) by its interaction with PNPase. The absence of PNPase almost certainly
changes the physiology of E. coli and it may be these changes that account for the
increased ability of T7 to grow in the presence of F.
b). Gp1.2 does not interact with gp10A. Although genetic analyses did not
suggest a specific interaction between gp1.2 and gp10A, overexpression of
nontoxic mutant T7 gene 1.2 permits wild-type T7 to grow in male cells, indicating
that the nontoxic gp1.2 not only competes with wild-type gp1.2 for PifA but also
prevents gp10 from triggering exclusion (Garcia and Molineux, 1995a). It was thus
of interest to ask whether mutant gp1.2 sequesters gp10A from PifA. Gp10A was
incubated with both his-tagged wild-type and mutant gp1.2 separately; however,
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no binding could be detected. Co-immunoprecipitation also failed to show that
gp10A binds to gp1.2 (data not shown). Therefore these two proteins probably do
not interact.
 3). FxsA interacts with T7 gp10A and gp1.2
PifA has been shown to interact with both gp10A and gp1.2 and their
interaction is believed to trigger the abortive infection of T7. Other than through
interacting with PifA, FxsA could also mediate protection by binding to gp10A or
gp1.2, thereby preventing their interaction with PifA. To test this idea, a cell
extract containing FxsA was incubated with resin bound with his-10A or his-1.2
and the eluate was analyzed by immunoblotting. FxsA binds to both gp10A and
gp1.2 (Fig. 23). The stability of the interaction between FxsA and gp10A or gp1.2
was measured by dissociating the complex with various concentrations of NaCl.
FxsA was eluted from both resins with 100 mM NaCl (data shown as part of Table
10).   
Summary of biochemical studies.
PifA interacts with gp1.2, gp10A and FxsA, FxsA with gp1.2 and gp10, but
no interaction between gp1.2 and gp10 was detected. Those mutations in gp1.2 and
gp10 that allow T7 to escape F exclusion reduce their binding affinity for PifA.
These results strongly suggest that the interaction of these proteins triggers F
exclusion. The apparent dissociation constant Kd for a gp10A-PifA complex is
lower than that of a gp1.2-PifA complex and both Kd values are about the same as
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Figure 23.  FxsA interacts with gp1.2 and gp10A.
Cell extracts of FxsA were incubated with  his-1.2, his-10A or a control his-
RNAP resin. Each eluate was subjected to SDS-PAGE and immunoblotted using
anti-FxsA serum
 KD  M     1        2       
KD     M      1         2          
   B  A
 52-
 36-
 29-
 20-
52 -
36 -
29 -
20 - FxsA
 81- 81-
 gp10A   RNAP
 gp1.2   RNAP 
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the concentrations of these proteins in F+ cells. Therefore, the Kd values obtained
in vitro likely reflect physiologically significant interactions in vivo. FxsA was also
found to bind PifA, gp1.2 and gp10A, supporting the idea that FxsA suppresses F
exclusion by interfering with PifA binding its cellular target, gp1.2, or gp10A.
A working model for exclusion of T7 by F.
Based on the results of previous and current studies, a model for exclusion
of T7 by F is suggested. PifA exists as an inactive form in the absence of gp1.2 and
gp10. After T7 infection, PifA is activated by gp1.2 or gp10 through a direct
interaction. The activated PifA then interacts with its cellular target and affects its
function. PifA may initially bind to the cellular target prior to phage infection. It is
possible that the cell target is a cytoplasmic membrane protein that has the capacity
to form an ion channel or that it is a component of binding–protein–dependent
transport system; alternatively, it could be the phospholipids that comprise the cell
membrane itself. The functional change of this cellular target caused by its
interaction with PifA results in an increased membrane permeability due to either
an enlargement of ion channels or a structural perturbation of some integral
membrane protein or the phospholipid bilayer. Consequently, the membrane
potential is lost, the energized membrane collapses, and all cell functions
associated with the membrane are therefore affected. FxsA interferes with the
interaction between PifA and gp1.2 or gp10, or the interaction between PifA and
its cell target by sequestering these parasites’ proteins, thereby preventing them
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from interfering with the function of the membrane or membrane protein. It is also
possible that FxsA helps maintain the integrity of cell membrane. Like the effects
of PifA (Wang et al., 1999b), that of FxsA is quantitative, its protective function is
effective only when sufficient levels of FxsA are present.
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Chapter 4.  Future Directions
In this study, PifA has been demonstrated to directly interact with both
gp10A and gp1.2 in vitro with a sufficiently high affinity that suggests comparable
interactions also occur in vivo. These interactions are likely the initial steps in the
process of F exclusion. The membrane localization of PifA and the demonstration
that membrane domains of FxsA are essential for suppressing F exclusion provides
direct evidence that the cell membrane is the site where gp10A and gp1.2interact
with PifA. This evidence further suggests that the cellular target of these proteins
is also localized in the membrane.
Because gp1.2 and gp10 interact with FxsA and both are cytoplasmic
proteins, the cytoplasmic domain of FxsA is probably the region for this
interaction. To determine whether this cytoplasmic loop of FxsA is required in
suppressing F exclusion of T7, alanine scanning mutagenesis or selective deletion
of a few residues of this domain might prove very informative. Cells synthesizing
the mutant FxsA would be tested for their ability to suppress F exclusion. To avoid
problems associated with possible changes in membrane topology with
mutagenesis, the positively charged residues, arginine 48, lysine 53 and lysine 61,
should not be substituted (except for the conservative R->K and K->R changes) or
deleted because they are crucial to anchor the second transmembrane segment. A
complete replacement of the entire cytoplasmic loop with a different cytoplasmic
sequence from a well defined inner membrane protein could also be performed. By
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examining the protective function of such FxsA hybrids, it should be easier to
judge whether the cytoplasmic sequence is required for suppression of F exclusion.
To ensure that any loss of protective function is not due to a change in membrane
topology, proteinase sensitivity of FxsA in both spheroplasts and inverted
membrane vesicle will be assayed.
Although the protease sensitivity assays performed in this work showed
that PifA may have a periplasmic domain, the PifA-PhoA fusion study did not
provide any supporting evidence. Whether PifA is an integral or membrane-
associated protein remains unclear but it will be necessary to resolve the question
in order to understand the mechanistic basis of F exclusion. Knowing whether PifA
has a periplasmic domain might also be useful in assessing the normal function of
PifA in F biology; it seems unlikely that the autoregulated pif operon is maintained
by F simply to prevent the spread of T7 and many of its close relatives.
Furthermore, several R plasmids are known to interfere with T7 growth (Meynell
et al., 1967), perhaps through similar mechanisms to PifA, suggesting that pif
maybe widespread on conjugative plasmids. It has been shown that the region
between residues 181 and 462 contains sequences that are at least partially
responsible for the membrane association of PifA. The protease sensitivity assay
also suggested that a potential cleavage site may lie between codons 332 and 381
but eight phoA fusions to this region did not allow phosphatase activity as judged
by blue colonies on XP plates. Although additional fusions could be made it is
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hard to justify doing so without additional independent evidence that suggests a
transmembrane segment(s) could be present. The K59A mutation of PifA abolishes
F exclusion but still allows PifA to bind gp1.2 and gp10, indicating that a domain
including lysine 59 may be involved in the interaction with its cellular target or
that this residue may be critical for the structural conformation required for the
interaction. Regional mutagenesis around lysine59 may help to define this domain
or identify other residues that are important for the function of PifA.
Searches of the data bases for proteins with similarity to PifA have not yielded
many clues to PifA function.  R64, a plasmid that, like F, inhibits T7 growth
(Hughes and Meynell, 1973), contains an almost identical gene to F pifA.  A
pathogenicity island in uropathogenic E. coli strain 536 codes for a protein closely
related to PifA.  Predicted proteins of unknown function from various bacterial
genera (both Gram negative and Gram positive) are somewhat related to PifA and,
interestingly, a predicted protein from a cryptic prophage of Salmonella
typhimurium also has similarity to PifA. Patches of the PifA amino acid sequence
show similarity to a number of ABC transporters and other ATP-binding proteins,
similarities are centered around the predicted P-loop of PifA but neither ATP nor
GTP binding could be demonstrated. Perhaps, as suggested earlier, use of a photo-
activated cross-linking ATP derivative would reveal an interaction.
By using affinity chromatography no E. coli protein was found to interact
with PifA and gp10. This indicates that any interaction between a host protein and
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those of the parasites is weak. A more sensitive assay might reveal an interaction.
Chemical cross-linkers, e.g., dithiobis-(succinimidyl propionate) is a commonly
used thiol-cleavable reagent (Gunzburg et al., 1989) that could be employed.
Crosslinks could be made in vivo by incubating the reagent with cells
overproducing his-tagged PifA, gp1.2 or gp10 or in vitro by incubating the cross-
linker with cell extracts prior to affinity chromatography. A yeast two-hybrid
screen with PifA, gp1.2 or gp10A as bait to screen an E. coli genomic library is
another approach to find interacting proteins. However, because PifA is a
membrane associated protein, it likely binds to its cellular target before infection
by T7. Thus it would be initially more useful to search for a PifA-interacting
component.
It has been suggested that the cellular component targeted by PifA and
gp1.2 or gp10 is likely localized in the membrane and may be crucial for viability.
However, there is no a priori reason that the component must be protein and it
could be the membrane itself. Phospholipids could be the target. If this idea is
correct it might explain why mutations affecting the target of PifA and gp1.2 or
gp10 were not isolated in several mutant searches.
The E. coli membrane contains 70-80% phosphatidylethanolamine(PE), 15-
20% phosphatidylglycerol (PG) and 2-5% cardiolipin (CL). Strains lacking PE or
CL are viable but the former need 50 mM MgCl2 in order to grow. Strains lacking
PG have also been isolated (Kikuchi et al., 2000) and a strain was made in which
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the levels of PE and CL can be controlled by IPTG (Heacock and Dowhan, 1989).
E. coli mutants containing an altered phospholipid composition could be tested for
their ability to support T7 growth and, if so, whether F exclusion still functions. In
principle F exclusion should be affected if the strain lacks the type of
phospholipids that is targeted by exclusion system.
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